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LABORATORY MOUSE MODELS FOR BARTONELLA BACTERIAL INFECTION: 
BACTEREMIA, HOST SPECIFICITY, AND PATHOLOGY 
  
 
     Bartonella bacterial species are globally distributed in a diverse variety of 
mammalian reservoir hosts. Natural host infections are generally 
characterized by persistent bacteremias of long duration, seemingly without 
adverse host effect, whereas non-natural host infections can produce mild, 
self-limiting illnesses or more severe disease such as endocarditis. Incidental 
host infections seem to most closely resemble natural host infections when 
the taxonomic distance between the two hosts is small. The greater the 
taxonomic distance between the host of origin and the incidental host, the 
more likely it seems that the incidental host will either clear the bacteria or 
develop pathology following exposure. This level of bacterial host specificity 
has been demonstrated consistently and presents an enormous obstacle to 
the development of animal models, particularly murine models that 
reproduce characteristics of natural host infection or pathology consistent 




     In this dissertation laboratory mouse models for bartonella infection are 
described following the introduction and literature review (Chapter 1). 
Chapter 2 reports infection of mice with bartonella strains from wild Mus 
species, simulating a cross-species host switch for the bacteria. Infected mice 
exhibited characteristics consistent with reports of natural rodent host 
infection. Chapter 3 reports on a mouse infection study using four rat 
bartonella strains, simulating a cross-genus host switch for the bacteria. Only 
one of the strains infected mice and alterations in bacteremia duration and 
magnitude were observed relative to those reported for natural host 
infections. Mice also displayed organ pathology following bacteremia 
resolution. Chapter 4 presents a mouse infection study using an Asian house 
shrew Bartonella elizabethae strain inoculated into three different laboratory 
mouse stocks. Mice of all three stocks developed bacteremia following 
bacterial exposures, a demonstration of cross-order host switching by the 
bacteria. No obvious differences in infection response were observed among 
the mice despite differences in their genetic backgrounds. Chapter 5 
describes inoculation of aged mice with either a mouse bartonella strain or 
human Bartonella tamiae strains. Mice infected with the mouse strain 
developed bacteremia, whereas mice infected with B. tamiae did not, 
consistent with the idea that taxonomic distance between host of origin and 






     Chapter 6 details results of a study where aged mice were exposed to 
three different B. tamiae strains. The mice developed disease consistent with 
reports of human illness symptomatology. In summary (Chapter 7), these 
laboratory mouse models are presented as defined, scientific resources for 
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CHAPTER 1  
 
BACKGROUND AND LITERATURE REVIEW 
 
THE GENUS BARTONELLA 
     Bacteria in the family Bartonellaceae are grouped in the class 
Alphaproteobacteria, phylum Proteobacteria, order Rhizobiales according to 
their 16S rRNA gene sequences. Today, species in the genus Bartonella 
include bacteria formerly known as Rochalimaea and Grahamella as well as 
the only original named species of Bartonella, B. bacilliformis. Until 1993 the 
genera Bartonella and Rochalimaea were classified in different families in the 
order Rickettsiales (Bartonellaceae and Rickettsiaceae) [1]. However, a 
thorough molecular investigation into the taxonomic relationships of these 
bacteria demonstrated a very low level of relatedness (0-2%) between them 
based on DNA hybridization assays of related sequences [1]. B. bacilliformis 
and Rochalimaea species were more closely related to one another than to 
the rickettsiae and ultimately proved more closely related to Brucella, 
Agrobacterium, and Rhizobium than to Rickettsia. Additional evidence for the 
new taxonomic placement of the species included differences among 16S 
rRNA sequences, the guanine: cytosine nucleic acid content of the genomes, 




Grahamella species also be reclassified under the genus Bartonella based on 
the same criteria [2]. The genus was therefore once again emended and two 
Grahamella species, G. talpae and G. peromysci, were added to the list of 
Bartonella species as B. talpae comb. nov. and B. peromysci comb. nov. The 
type genus for Bartonella has remained throughout these changes as 
described by Tyzzer, Strong, and Sellards in 1915 and the type species for 
the genus is B. bacilliformis. With the reclassification of the other bacteria 
and the addition of several new species a total of ten Bartonella species were 
recognized in 1996. 
     Since the consolidation of the family Bartonellaceae, numerous new 
Bartonella species have been described. Today there are 40 named or 
proposed (candidate) species in the genus Bartonella (Table 1.1). The rapid 
expansion of the genus in the last decade is mainly attributable to 
improvements in detection methodologies. Molecular genetic detection of 
bacterial DNA has been improved by increasing the sensitivity and specificity 
of PCR assays [3-7], while new and improved techniques for growing bacteria 
in eukaryotic cell culture aid in the detection of novel species [8-10]. 
Modified insect growth media (Schneider’s drosophila liquid medium, insect 
growth medium DS2) have also been successfully used for bartonella culture 
[11, 12]. The increasing rate of discovery of new Bartonella species is also 
attributable to heightened surveillance for the bacteria as agents of human 
illness and the discovery of novel species in wildlife (Table 1.1) [13, 14].   
     New species are typically identified and described based on the proportion 




Table 1.1 According to a literature survey there are 40 recognized or 
candidate (proposed) Bartonella species and subspecies which have been 
isolated from a variety of animals worldwide (English language, PubMed and 
Web of Knowledge). The source (S) annotation indicates hosts from which 
novel bacteria were isolated; (R) indicates a reservoir host (R).   
  
Species 
Animal source (S) and/ 
or reservoir (R) Ref. 
B. alsatica Rabbits (R) [15] 
B. australis Eastern grey kangaroos (R) [16] 
B. bacilliformis Human (R) [17] 
B. birtlesii Mice (Apodemus spp.) (R) [18] 
B. bovis Cattle (R) [19] 
B. capreoli Ruminants (R) [5] 
B. chomelii Ruminants (R) [20] 
B. clarridgeiae Cats (R) [21] 
B. coopersplainensis Rats (R) [22] 
B. doshiae Voles (Microtus spp.) (R) [2] 
B. elizabethae Human (S), rodents (R) [1, 23] 
B. grahamii 
Voles (Myodes spp., formerly 
Clethrionomys spp.) (R) [2] 
B. henselae Cats (felines) (R) [24] 
B. japonica 
Small Japanese field mouse  
(Apodemus argenteus) (R) [25] 
B. koehlerae Cats (R) [26] 
B. peromysci Mice (Peromyscus spp.) (R) [2, 17] 




Table 1.1 continued. 
Species 
Animal source (S) and/ 
or reservoir (R) Ref. 
B. queenslandensis Rat (R) [22] 
B. quintana Human (R) [1] 
B. rattaustraliani Rat (R) [22] 
B. rattimassiliensis Rat (R) [27] 
B. rochalimae Human (S),  [28] 
B. schoenbuchensis Roe deer [29] 
B. silvatica 
Large Japanese field mouse  
(Apodemus speciosus) (R) [25] 
B. talpae Shrew mole (R) [2, 17] 
B. tamiae 
Human (S), Trombiculid mites 
(S), (R) unknown  [30] 
B. taylorii Mice (Apodemus spp.) (R)  [2] 
B. thailandensis Rat (Rattus surifer) (R) [31] 
B. tribocorum Rat (Rattus norvegicus) (R) [32] 
B. vinsonii subsp. arupensis Mice (Peromyscus spp.) (R) [33] 
B. vinsonii subsp. berkhoffii Dogs (canines) (R) [34] 
B. vinsonii subsp. vinsonii Voles (R) [36, 37] 
B. washoensis 
Human (S); Ground squirrel 
(Spermophilus beecheyi) (R)  [38, 39] 
B. washoensis subsp. 
cynomysii 
Prairie dogs (R) 






Table 1.1 continued. 
Species 
Animal source (S) and/ 
or reservoir (R) Ref. 
Candidatus B. antechini 
Fleas (Acanthopsylla jordani) (S) 
Ticks (Ixodes antechini) (S)  
Antechinus flavipes (Mardos or 
Yellow-footed antechinus) (R?)] [40] 
Candidatus B. durdeni 
Flea (Orchopeas howardi) (S) 
Eastern US gray squirrels  




mayotimonensis Human (S), Unknown (R)  [43] 
Candidatus B. melophagi Sheep (S, R?), Sheep keds (S)  [44] 
Candidatus B. monaxi Groundhog (Marmota monax) (R?) 
[41, 
42] 
Candidatus B. volans 
Southern flying squirrel  




gltA, ftsZ, groEL, ribC, and the ITS (RNA polymerase subunit B, citrate 
synthase, filamenting temperature-sensitive mutant Z, 60-kDa heat shock 
protein (GroEL), riboflavin synthase, and intergenic transcribed spacer 
region, respectively) [45]. Identification of a new species is based on the 
isolate meeting two criteria. First, a 327 bp sequence of its gltA cannot share 
more than 96.0% identity with currently recognized species and second, an 
825 bp sequence of its rpoB cannot share more than 95.4% sequence 
similarity to recognized species [45]. Recognition of new Bartonella species 
has been complicated by the inability of some investigators to culture type 
strains for new species they have discovered and characterized using 





     Bartonella bacteria are small, <3µm in diameter, Gram negative staining 
coccobacilli [17]. They are aerobic and can be grown on microbiological 
plates but must be incubated in a 5% CO2 atmosphere. Agar media for 
growth of these fastidious bacteria must be protein rich (e.g. brain heart 
infusion, heart infusion, or tryptic soy) and is often supplemented with 5—
10% blood, usually from sheep or rabbits, to satisfy their high hemin 
requirements [17]. Bartonellae grow at temperatures ranging from 22—37°C 
which mirrors their ability to survive and grow in ectothermic arthropod 
vectors as well as in endothermic mammalian hosts [8, 46-48].    
     Bartonellae as facultative intracellular microparasites are able to infect a 
number of different mammalian cell types. Eukaryotic cell cultures derived 
from primate, cat, and mouse tissues are commonly used to grow bacteria 
for diagnostic or research purposes as they can easily infect these cells [8, 
49-51]. Infection assays have also demonstrated that B. henselae can invade 
embryonic tick cell lines derived from Amblyomma americanum, Ixodes 
scapularis and Rhipicephalus sanguineus, respectively [52]. Nine other 
bartonella strains are capable of infecting the A. americanum cell line [52]. 
This promiscuity for a variety of cell types in vitro reflects on the capacity of 
many species to infect different host taxa.     
     Bartonella bacteria have circular chromosomes ranging from 1.5—2.6 Mb 
in size. Five species have been sequenced: B. bacilliformis (GenBank 
accession no. CP000525), B. henselae, B. quintana, B. tribocorum, and B. 




content of these species indicates they have undergone reductive genome 
evolution, a common finding for alphaproteobacteria that live an intracellular 
lifestyle [55]. Following radial speciation from an ancestral lineage modern 
species show evidence of genome expansions beyond the shared ancestral 
gene array. Some Bartonella species carry plasmids such as the cryptic 
plasmids pBGR1, pBGR2, and pBGR3 found in B. grahamii which can be 
shared among Gram negative bacteria by conjugation [56]. Integrated phage 
sequences have also been found in some species and can act in the lateral 
transfer of genetic material between bacteria [57]. These integrated pro-
phages can also duplicate portions of the bacterial host chromosome during 
run-off replication [53], a potent mechanism for increasing genetic diversity.  
Interactions with eukaryotic host cells 
     Relatively few pathogenesis factors have been identified for bartonella 
bacteria, the most important of which are reviewed below. Research in this 
area has overwhelmingly been aimed at elucidating the mechanisms for 
bacterial entry into host erythrocytes and/or endothelial cells and for 
inducing vasoproliferation. Most of these experiments have been conducted 
in vitro using eukaryotic cell lines such as HUVEC or Ea. hy926 (human 
umbilical vein endothelial cells), HeLa229 (human epitheloid cervix 
carcinoma), HMEC-1 (human microvascular endothelial cells) or J774 (murine 
macrophage cell line) [50, 58-61]. A number of studies have been done in 
vivo in a rat (Rattus norvegicus) model using B. tribocorum [62-64]. 
     Bartonella bacteria contain structurally modified lipopolysaccharide (LPS) 




infection and large amounts of circulating LPS in infected patients can trigger 
septic shock [65]. Bartonella LPS appears not to exert this effect as natural 
reservoir hosts for many strains maintain long term bacteremias without 
deleterious effect to the host [66, 67]. The LPS of B. henselae has some 
structural modifications that it shares with LPS of other intracellular bacteria 
such as Legionella and Rhizobium species [66]. Penta-acylation of lipid A is 
the major structural variation in the LPS associated with decreased endotoxic 
potential [66].     
     Bartonella bacilliformis, B. clarridgeiae, B. schoenbuchensis, B. chomelii, 
B. capreoli, and B. rochalimae have flagella [19-21, 28, 29, 68]. Flagella are 
cell surface structures that confer motility to bacteria [69]. The flagella of B. 
bacilliformis have been shown to play a role in erythrocyte binding and 
invasion though they are not the only determinants of host cell entry [68, 
70-72]. On the other hand functional flagella do not appear necessary for B. 
clarridgeiae to invade HMECs in vitro [73]. Two non-motile B. clarridgeiae 
mutants were created by site specific mutagenesis of  the flagellin gene, flaA, 
and the flagellar motor genes, motBC. The mutants displayed a reduction in 
binding, or enhanced invasion, respectively, but no absolute loss of cell entry 
was observed during in vitro assays [73]. The role of flagella has not been 
investigated for the other four species, and no in vivo model exists for 
evaluating it. 
     Other strategies for erythrocyte or endothelial cell entry have been 
investigated and detailed. For B. bacilliformis this includes the use of the 




permeability and the use of invasins which are encoded by ialA-B (invasion 
associated locus) [74, 75]. A role for filamentous hemagglutinin in host cell 
adherence and entry has been hypothesized for bartonellae based on the 
presence of genetic homologs for these structures in B. henselae [76, 77]. In 
Gram negative bacteria adhesins (FhaB and FhaC/HecB) interact to form a 
periplasmic protein structure that spans the outer membrane and projects 
from the bacterial surface [76, 78]. During in vitro infection studies with B. 
henselae in HEC designed to monitor the activity of the BatR/BatS regulon, 
the genes encoding the filamentous hemagglutinin were upregulated along 
with other genes implicated in host cell invasion [79]. Research to confirm 
the putative role of FhaB and FhaC/HecB in host cell entry is needed.     
     Two type 4 secretion systems (T4SS), Trw and VirB-D4-Bep (Bep: 
Bartonella-translocated effector proteins) have been described in Bartonella 
species [57, 64, 80-82]. The T4SSs evolved from bacterial conjugation 
machinery and consist of up to 11 proteins which when assembled form a 
pilus and pore complex spanning both bacterial and host cell membranes 
[80, 83]. Bacterial effector proteins can be transported through these 
structures into the host cell cytoplasm [80, 83].  
     The specific function of the VirB-D4-Bep T4SS has been investigated in 
vitro for B. henselae [84], and in a rat model for B. tribocorum [85]. 
Bartonella henselae VirB4/D4 mutants showed significant impairments in 
their ability to mediate and/or abrogate host cell responses during HUVEC 
infection [84]. Expression of virB4/D4 is necessary for bacterial cell entry via 




the host cell’s actin cytoskeleton [49, 86]. VirB4/D4 B. tribocorum mutants 
lost the ability to establish erythrocyte infection in rats compared to wild type 
bacteria [64].  
     The role of the Trw T4SS has been most extensively investigated in the B. 
tribocorum-rat model [63, 81]. It appears that the primary function of this 
T4SS is to mediate binding to host erythrocytes by constructing a pore and 
pilus complex, and not to transport bacterial effector proteins. In fact, the 
Trw T4SS has no VirD4 homolog, a protein which is required for the transport 
of Bep. TrwE deletion mutants could not establish erythrocyte infection in 
rats compared to wild type bacteria [81]. Because of its demonstrated role in 
erythrocyte binding the TrW is also believed responsible for the differential 
infectivity, i.e. host specificity, of different Bartonella species for different 
animal hosts [63, 81].  
      Phylogenetic relationships between different Bartonella species Trw 
systems have been investigated to identify influences on the evolution of 
host specificity [54]. In B. henselae gene sequences for the proteins that 
make up the Trw T4SS have been duplicated with as many as 7—8 copies of 
a single gene represented [87, 88]. An even greater number of copies exists 
in B. tribocorum and B. grahamii. These gene duplications have produced a 
high level of variability in the Trw pilus proteins [88]. Since the Trw pilus is 
involved in erythrocyte adherence and invasion, it is hypothesized that this 
variability is responsible for the erythrocyte host ranges of these bacteria 




mammalian hosts may have been an evolutionary driver for diversifying 
selection of the Trw [88].  
     Bartonella species are the only bacteria known to induce vasoproliferation 
during human infections. Bartonella bacilliformis stimulates the growth of 
vasoproliferative lesions known as verruga peruana, and B. quintana and B. 
henselae can induce bacillary angiomatosis and hepatic peliosis in humans, 
usually but not always in immunocompromised patients [89]. The 
mechanisms and effector proteins involved in these syndromes remain 
largely unknown and understudied.  
     Bartonella adhesin A (BadA) is a trimeric autotransporter adhesin, a 
member of a class of virulence factors common among Gram negative 
bacteria [90]. The protein constituents of this nonfimbrial adhesin form a 
construct consisting of a ‘head, neck, stalk, and membrane anchor’ that can 
transport effector proteins into the host cell cytoplasm [90, 91]. Expression 
of BadA is necessary for adherence of B. henselae to collagen covered glass 
coverslips and the head of BadA is required for binding of B. henselae to 
HUVECs [91]. Bad A also plays a role in activation of HIF-1 (hypoxia-
inducible factor-1) during angiogenesis [90-92]. A homologue to BadA is 
present in B. quintana, the VompA-D (variably expressed outer-membrane 
proteins A-D). Though it has not been as extensively investigated as BadA in 
B. henselae, VompA-D appears to function in much the same way [60, 93, 
94].   
     The upregulation of HIF-1 in B. henselae infected HeLa cells has been 




in transcription and secretion of VEGF (Vascular Epithelial Growth Factor) in 
vivo [92]. Secretion of VEGF leads to vasoproliferation [51, 92]. This pattern 
of angiogenesis has been previously observed in response to cellular hypoxia 
in tissues, such as cardiac ischemias, and also in tumor-related tissue 
remodeling [92]. Understanding the pathways for induction of vascular tissue 
growth has implications for therapeutic applications if the nature and role of 
bacterial effector proteins in this process can be discovered. Attempts have 
been made to develop an in vivo model for the study of this type of 
vasoproliferative lesion but have so far proven unsuccessful (Table 1.3).  
Genetic and geographic diversity of bartonella strains 
     Except for B. bacilliformis, the sole survivor of an ancient bacterial 
lineage, all bartonellae appear to be derived from the same modern lineage 
by radial speciation [54]. These modern bacterial species commonly exist in 
nature as circulating genotypic variants most often associated with one or 
more predominant reservoir hosts [80]. The geographical and evolutionary 
relatedness of diverse bacterial strains has been investigated and it appears 
that strain diversification is associated with strain introductions into new 
locations with or without concomitant host shifts (or host switches) [95-97].  
     The rodent-associated bacterium B. grahamii is globally distributed and 
commonly isolated from a variety of rodent genera such as Apodemus, 
Arvicola, Dryomus, Microtus, Mus, Myodes, and Rattus spp., indicating a 
broad host range for this species [98-102]. Because of these characteristics 
and because it has been sequenced (2.3Mb), it is highly suitable for 




[53]. Most of the inferences made about mechanisms underlying the genetic 
and geographic diversification of rodent-associated bartonellae comes from 
genomic analyses of B. grahamii strains.   
     Genetic diversification in B. grahamii is quite common. Genes believed to 
be involved in host adaptation are located within a region of the genome 
containing phage sequences that experiences run-off replication (or escape 
replication) [53]. Sequences duplicated through this process can be selected 
upon or can mutate without affecting the integrity of the chromosome as a 
whole, so bacteria can diversify and adapt to new ecological niches easily. 
Strains of this species have high recombination rates and evidence for lateral 
gene transfers shows genetic exchanges occurring among different species 
that share hosts in rodent communities [53, 103]. This has been inferred 
among B. grahamii strains and between B. grahamii and B. taylorii, another 
species that commonly infects some of the same rodent hosts as B. grahamii 
[97, 103]. Recombination events within even a single species can explain 
genotypic variance among strains. Whether this variance plays a part in 
defining a strain’s host range is unknown, but likely [96].      
     Geographic diversification of bartonellae can be easily conceptualized on a 
framework of large geographic distances and the biogeographic 
diversification and dispersal of rodents. However, genetical analyses of B. 
grahamii isolates from three locations within 30km of one another showed 
diversification even at such a small geographic scale [96]. The 20 strains 
analyzed had low sequence diversity, a low number of single nucleotide 




showed a level of diversity that could be correlated with their geographic 
origins [96]. This demonstrates that evolution and selection of differing 
genotypes/genomotypes can occur within very small areas and be driven by 
differences in rodent hosts, local ecology, and founder effects.  
     An intriguing last note on bartonella strain diversification is the 
suggestion that interactions between bartonella strains or between different 
bacterial species within a vector might contribute to strain diversity [104]. 
Horizontal gene transfers can potentially occur between bacteria inhabiting 
arthropod vectors in the gut or elsewhere. The environment within the vector 
would be vastly different than within a mammalian host and bacterial strains 
could potentially diversify to exploit that niche. 
ECOLOGY OF ZOONOTIC BARTONELLAE 
     Bartonella bacteria can be broadly grouped into two categories: species 
that have man as their natural reservoir host and species that naturally infect 
mammalian hosts other than man. The human pathogens B. bacilliformis and 
B. quintana are arthropod-borne bacteria with the sandfly Lutzomyia 
verrucarum and the human body Pediculus humanus (Linnaeus, 1758) as 
their primary vectors, respectively [105]. All other known bartonella species 
are known or believed to be maintained in transmission cycles in non-human 
animal reservoirs [106-108].  
     Bartonellae have been isolated from rodents and other wildlife from six of 
the seven continents. Mammalian reservoirs encompass ungulates, rodents, 
insectivores, lagomorphs, carnivores, marsupials, and chiropterans (Table 




possible by the presence of a persistent bacteremia in natural reservoir hosts 
which is thought to facilitate bacterial acquisition by arthropod vectors [109]. 
The ability of bartonella bacteria to induce a persistent, non-pathogenic 
bacteremia is a unique parasitic strategy among bacteria and infections can 
last a year or more [110, 111]. This phenomenon is believed to be a result of 
a high level of adaptation of the bacteria for its natural hosts, as they appear 
able to maintain long term bacteremias without apparent adverse effects 
[108, 109, 111, 112]. Though this presumption has not been extensively 
investigated there is indirect evidence to support this hypothesis, several 
examples of which are noted below. No angiogenic lesions were found in 
tissues of over 100 naturally infected small woodland rodents examined 
histopathologically [109]. Bartonella infected fat sand rats (Psammomys 
obesus) sampled over a three year field study in Tunisia showed no effect on 
body mass or onset of sexual maturity relative to uninfected rats [113]. 
Observations from an experimental infection study of B. tribocorum in its 
natural host, Rattus norvegicus, also support the presumption that 
bartonellae do not commonly exert detrimental effects in their natural hosts 
[62]. In that study B. tribocorum parasitized erythrocytes in infected rats 
showed no alteration in either lifespan or functionality, though as many as 
107 bacteria were present in 1ml of blood [62].  
Natural history of bartonellae infections in rodents 
     The natural history of bartonellae has been investigated in a few wildlife 
reservoir hosts but it is still not well understood. Some host species seem to 




only a few. Rodents in particular are reservoirs for numerous strains 
representing a large proportion of the diversity reported for the bacteria 
[108]. Recently published surveys on bartonellae in bats reveals strain 
diversity rivaling that observed in rodents [13, 14, 114]. Many other 
mammals harbor bartonella species but with less strain diversity (Table 1.1).  
     Bacterial host specificity seems to be a powerful determinant for the 
distribution of bartonella strains infecting small mammal populations. This 
phenomenon seems common in wildlife populations and indirect evidence for 
host specificity can be found in many rodent populations by simply 
comparing the relative prevalences of infection with different bartonella 
strains among different rodent taxa within an ecosystem. Specific 
associations between rodent taxa and circulating strains are also often 
apparent. 
     In some ecosystems the most abundant rodent species may be infected 
with a host specific dominant bartonella strain. This was seen with three 
cotton rat strains of bartonella circulating in cotton rats, Sigmodon hispidus, 
a species of New World rodent, in Georgia (species A, B, and C), and in the 
western U.S. in deer mice, another New World rodent, which are commonly 
infected with four different strain variants (D1—4) [115-117]. The dominant 
strains were infrequently detected in other rodent community species despite 
a presumptive high degree of exposure of naive rodents to infected hosts. 
Although the nature and frequency of inter-specific contacts between many 




that contacts occur continuously since rodents will share or compete for 
many resources [118-120].  
     Studies conducted in the U.K. initially refuted the influence of host 
specificity on the distribution of bartonella strains among examined rodent 
communities, but later more in-depth studies of infection prevalence, 
seasonal dynamics, and host densities revealed that these strains were host 
specific [121-124]. Assuming that bacterial host specificity commonly exists, 
it explains why bartonella infection prevalences in ‘non-natural’ host 
populations surveyed in these studies never approaches the natural host 
population infection prevalence.  
     An experimental infection study using the bartonellae isolated from cotton 
rats further defined their host specificity among different rodent taxa, and 
confirmed bacterial host specificity as a determinant for the distribution of 
infections among rodents [125]. Three different cotton rat bartonella strains 
failed to infect Wistar rats (Rattus norvegicus), white-footed mice 
(Peromyscus leucopus), and BALB/c mice (Mus musculus) though bacterial 
doses were as high as 107 cfu [125]. Experimental infection studies of mice 
with different Bartonella species also reveals high levels of bacterial host 
specificity (Table 1.3).  
     Though bacterial host specificity seems to operate within, among, and 
between most mammal taxa there are at least two small mammal hosts 
inhabiting different ecosystems that appear permissive to infection by diverse 
strains. The North American grasshopper mouse (Onychomys leucogaster) 




frequently infected with a variety of genotypes. Four of 10 genotypes 
detected in grasshopper mice were identical to genotypes found in other 
rodent genera [126]. The presence of variants in grasshopper mice 
correlated with the abundance and population infection prevalence of those 
variant’s primary host [126]. When these indices were high, grasshopper 
mice were more likely to be infected with these other variants.       
     In Asia the Oriental house shrew Suncus murinus appears to be 
permissive for infection with bartonella strains that most commonly circulate 
in Rattus and Apodemus spp. [127-129]. Both shrews and rats inhabit 
peridomestic environments in Asia and share a common ectoparasite fauna 
[130-132]. Contacts between rats and shrews and/or transfer of fleas 
between hosts is a likely explanation for this finding [133, 134].  
     The demographic features of many bartonella infected host populations 
have been investigated [108]. Small mammal populations tend to maintain 
fairly high bartonella infection prevalences. A multiplicity of studies has been 
done around the world to define circulating strains in reservoir hosts and to 
understand the distribution and dynamics of infection in these populations 
[108]. Rodent community composition and habitat appear to influence these 
parameters. A few examples of such studies and their findings are 
summarized below and a literature review of bartonella infection prevalences 
in wildlife populations was recently published [108].  
     Deer mice and cotton rats in the western and southern United States 
exhibit >80% and >90% population prevalences of bartonellae infection 




with five different Bartonella species had infection prevalences ranging from 
0.6—38.7% depending on the host-bacteria combination [124]. Woodland 
and grassland rodents were sampled in Poland: 46.3% of yellow-necked mice 
and 29.1% of bank voles in the forest were infected with bartonellae, and 
36.9% of common voles and 13.7% of root voles in grasslands were infected 
[135]. Numerous small mammal surveys have been done in various parts of 
Asia revealing an enormous array of circulating bartonella strains in tested 
animals [108]. Of the limited rodent genera that do not harbor bartonellae, 
interestingly it is Mus species that are most often not infected, though 
admittedly the capture rates for these rodents are not high [127, 129, 136-
138]. 
     Bartonella infection prevalence appears to be influenced by species 
diversity within rodent communities in the southwestern United States and 
northern Mexico [117]. Results from rodent trapping and blood sample 
testing of 24 rodent communities suggested that bartonellae transmission 
within these ecosystems was frequency-dependent [117]. Frequency-
dependent bartonella transmission is predicated on some level of 
demonstrated host specificity of bacterial strains for particular hosts. 
Otherwise the presence of additional rodents within the habitat would merely 
increase the size of the natural reservoir population. When bacterial strains 
exhibit host specificity for certain rodent species or genera then an increase 
in refractory host abundance within the community can result in a decrease 




     A dominant species effect was observed in 2 of 24 examined sites 
wherein the most abundant rodent species within the community showed 
relatively little or no evidence for bartonella infection [117]. These dominant 
populations are hypothesized to monopolize resources within the ecosystem, 
thereby regulating population abundance of other sympatric rodent species 
which could be more susceptible to bartonella infection. A similar 
phenomenon was observed in the United Kingdom when non-native bank 
voles were introduced into an ecosystem with a pre-existing bartonella 
susceptible wood mouse population [123]. The bank voles were resistant to 
infection with any of the circulating strains in the native rodent populations. 
Bank vole population density directly affected bartonella infection prevalence 
in the wood mice [123]. Increases in bank vole density correlated with 
decreases in wood mouse infection prevalence, an example of a dilution 
effect [123].   
     Bartonella infection prevalences in surveyed rodent communities in the 
United Kingdom appear to be primarily density-dependent [122-124]. Within 
a system of four Bartonella species and two rodent hosts, both direct and 
delayed host density played a role in infection distribution and prevalence 
within the rodent community. It is notable that levels of host specificity for 
the four bacterial species examined during these studies seem much lower 
than those observed in U.S. rodents [122-124]. 
     The influence of age, sex, and reproductive status on rodent bartonella 
infection prevalence has been assessed in several long term studies. 




defy generalizations. In some systems older sexually mature rodents are 
more likely to be infected than younger immatures [122, 139, 140], but in 
other communities the opposite is true [112]. Sex of the rodent does not 
generally appear to effect infection status but there are exceptions. Male 
cotton rats had significantly higher bacteremia levels than females in one 
study [112], and male yellow necked mice (Apodemus flavicollis) had both 
higher prevalence and abundance of infection than females [135].       
     Seasonality seems to influence transmission of some bacterial strains 
among hosts [122, 124, 140]. This could be due to correlations with rodent 
breeding seasons and the introduction of naïve young into the population 
[140]. Seasonality could also be linked to fluctuations in arthropod vector 
abundance and host infestation rates [122]. No strong correlations between 
arthropod vector abundance and infection prevalence and measures of rodent 
host infection prevalence have been reported. This could be due to a lack of 
resolution in looking at ectoparasite samples coupled with a lack of 
information on the dynamics of vector-borne transmission within a studied 
system [122]. For example, studies that sampled fleas failed to identify the 
samples to species and samples are commonly pooled for testing [122, 139, 
141]. 
     Indigenous bartonella strains will infect both native and introduced rodent 
species unless a host specific barrier exists. Strains found in non-native 
rodent species can be related to bacteria from geographic locations where 
the animals originally came from [99, 142, 143]. Furthermore, when 




the new strains, enabling detection of new strains through surveillance 
programs as they appear in new geographic locations. The often specific 
associations between rodent hosts and their bartonellae can permit both the 
animal source and region of origin to be deduced.   
Rodent responses to naturally acquired bartonella infections 
     Most information about individual rodent host responses to infection 
comes from a few long term field studies and a very limited number of 
experimental infection studies evaluating rodents and their adapted 
bartonella strains. The threshold dose for host infection is unknown for most 
rodent bartonella strains. Bacteremia duration observed for naturally infected 
hosts was up to 8 months in cotton rats, up to 4 months for field voles, and 
up to a year or more for deer mice [109, 111, 112, 115, 125].       
     Bacteremia levels in naturally infected hosts vary widely according to the 
rodent species and circulating bartonella strains present. Levels of 106 cfu/ml 
have been recorded for Sigmodon hispidus (cotton rats) [112], 105 cfu/ml for 
Rattus spp. [137], 104 cfu/ml for Neotoma spp. (woodrats) [140], and 104 
cfu/ml for Cynomys ludovicianus (black-tailed prairie dogs) [144]. Some field 
studies report categorical measures of bacteremia such as high or low [139] 
and others report on the number of parasitized red blood cells observed by 
microscopy in a blood smear [109, 113].  
     Bacteremia kinetics in naturally infected rodents usually seem to fall into 
one of four categories. Cotton rats and deer mice repeatedly captured during 
field studies showed patterns of relapsing bacteremias [111, 112, 115]. 




appeared to clear the infection only to test positive for the same bacterial 
strain during subsequent sampling. Cotton rats and deer mice both displayed 
such abacteremic intervals. In the cotton rat study, some individuals showed 
an initial high bacteremia level that declined continuously over time. A third 
pattern was characterized by an initially high bacteremia which declined over 
time then ‘spiked’ again [112]. An animal might also maintain a low 
bacteremia for some time then experience a large increase in bacteremia 
level after which the level would decline again [112]. Field voles naturally 
infected with Bartonella species also displayed two patterns of response: 
either an initial high bacteremia that declined steadily over time, or a low 
level persistent bacteremia [109]. The cotton rats were infected with three 
different bartonella strains which could account for some of the differences in 
response [112, 115, 125]. Exposure dose, individual host susceptibility, and 
immune status could also play a role in infection response.   
     Homologous host:bacteria experimental infection studies have been done 
with cotton rats and white-footed mice (Peromyscus leucopus) and results 
generally agree with field observations [145]. The 100% infective dose was 
different for each of the three different cotton rat bartonella strains 
evaluated, ranging from 10 cfu to 1000 cfu. Cotton rats demonstrated 
bacteremia levels up to 105 cfu/ml following infection with 3 of the 4 strains. 
All white-footed mice inoculated with 107 cfu of four different Peromyscus 
spp. strains became bacteremic (100%). The dose required to infect 50% of 
inoculated mice varied from 104 to 107 cfu, and some mice displayed 





Vector transmission of bartonellae among hosts 
     Dynamics of transmission among animals naturally infected with 
bartonella strains remains obscure though vector transmission of several 
Bartonella species has been demonstrated. Noguchi established mechanical 
tick transmission of B. bacilliformis as early as 1926 by removing partially fed 
ticks from infected monkeys and placing them on naïve monkeys which later 
developed infections [146]. Sandflies and the human body louse are 
uncontended vectors of B. bacilliformis and B. quintana among humans, 
respectively [105]. The cat flea, Ctenocephalides felis, is a demonstrated 
vector of B. henselae among cats [147], and there is in vitro, experimental 
evidence for tick transmission of B. henselae by Ixodes ricinus [148]. More 
recently I. ricinus transmitted B. birtlesii to mice in the laboratory [149].  
     Flea vector transmission of two rodent bartonella species was 
experimentally demonstrated. Wild-caught B. taylorii and B. grahamii 
infected fleas (Ctenophthalmus nobilis nobilis) were placed in a holding pen 
with their natural hosts, bank voles (Myodes glareolus, formerly 
Clethrionomys glareolus). The twenty wild-caught fleas were allowed access 
to 28 naïve, laboratory bred bank voles for 4 weeks. The fleas were sampled 
from a population previously demonstrated to have a 60% prevalence for 
Bartonella species infection. After 4 weeks,  21/28 (75%) of the bank voles 
were bacteremic: 16 were infected with B. taylorii, five were infected with B. 
grahamii, and one vole was infected with both species. The only source of 




borne transmission of the bacteria was indicated. Two-hundred and 
seventeen fleas were collected from the arena. Randomly sampled pools of 5 
fleas each as well as 10 individual fleas were tested for the presence of 
Bartonella species [150]. All 10 pools were positive for bartonella and 70% 
(7/10) of individual fleas were positive as well. Of those seven positive fleas 
four were positive for B. taylorii, one for B. grahamii, and two fleas were 
positive for the presence of both species [150]. Unfortunately, it is difficult to 
make inferences about the transmission efficiency of the fleas from this data. 
     A multiplicity of flea-borne mechanisms of transmission exists and it is 
possible for different mechanisms to be responsible for differing portions of 
natural transmission cycles. The infected fleas may have bitten the voles and 
thus transmitted the bacteria, the voles may have eaten the fleas, or the 
fleas may have excreted infectious feces that infected the voles through 
mucous membrane exposure or intradermal exposure following self-
scratching in response to flea bites.  
     The potential for horizontal and/or vertical transmission was also 
assessed in this study [150]. Eight male: female pairs of voles were caged 
together without fleas. For two pairs both voles were inoculated with B. 
taylorii, for two pairs only males were inoculated, and for four pairs only 
females were inoculated [150]. The vole pairs were kept approximately 10 
weeks, or until they had produced litters (7/8 pairs). Blood cultures 
confirmed that all needle inoculated voles became bacteremic, but no 
uninoculated adults or young were found bacteremic, i.e. no horizontal or 




born during the experiment were negative for bacteremia though they were 
suckling a bacteremic female [150].  
     Numerous ectoparasite surveys have identified potential vectors of 
bartonellae through PCR detection of bacterial DNA [151, 152]. 
Hematophagous arthropods are often implicated as vectors when either 
viable bacteria or bacterial DNA is detected in them, though vector 
competence for bartonellae has been established for very few arthropod 
species [149, 151, 152]. Experimental, ecological, and epidemiological 
evidence is lacking for a role in transmission of bartonellae for a majority of 
these arthropods [52, 152]. Recent studies are beginning to address these 
gaps in knowledge [148, 149, 153-155]. 
     Undoubtedly vector transmission of bartonellae does occur, but alternate 
transmission mechanisms may also be responsible for some proportion of 
transmission events in nature. There is some limited evidence implicating 
additional transmission modes. Bartonellae have been isolated from cotton 
rat and deer mouse embryos and neonates [156]. This suggests the potential 
for at least some Bartonella species to be transmitted vertically in their 
natural reservoir hosts [156]. Viable bartonella bacteria were detected in 
urine collected by cystocentesis from one cotton rat (M. Kosoy, personal 
communication). If urinary excretion of viable bartonellae occurs in rodents it 
may serve as a mechanism for environmental transmission of the bacteria 
[157]. 
     One of the continuing puzzles of bartonella ecology arises from 




strains detected in hosts from which those ectoparasites were removed [155, 
158-160]. First, not all ectoparasites removed from bacteremic hosts are 
positive for detection of bacterial DNA matching strains present in the host 
[141, 158]. Second, bacterial strains can be detected in ectoparasites that 
are not present in their hosts [160, 161]. If obligate blood feeding 
ectoparasites such as fleas or ticks are common vectors of bartonella strains 
among hosts it seems that all or most arthropods recovered from a 
bacteremic host should contain bacterial DNA. This is not always the case 
however. There are multiple explanations for this finding that do not 
contradict the widely held belief that arthropods commonly transmit 
bartonellae among hosts. Ectoparasites recovered from a host may have 
recently transferred from another animal [133, 134]. The efficiency of 
bacterial colonization of the ectoparasite may be low. A host may have been 
previously infected with another bacterial strain which has colonized the 
midgut of the vector, rendering it refractory to further colonization with a 
different bacterial strain. A host may be co-infected with different bartonella 
strains that demonstrate different growth characteristics in the ectoparasites 
than in their hosts [159]. This is plausible as mammalian hosts will maintain 
a steady body temperature, whereas ectoparasites are ectotherms subject to 
larger temperature fluctuations than their hosts. Strains that outcompete 
other bacteria in the host may in turn be out-competed in the vector. 
Arthropod vectors may also be more permissive to midgut colonization by 




infecting bacteria in arthropods may be low [159, 162]. It is possible that the 
incidence of co-infection is much higher than currently recognized [159].  
     The presence of bartonella strains in reproductive tissues of small 
numbers of rodent fleas of five species raises the question of whether 
bartonellae could be vertically transmitted by arthropod vectors [155]. 
Bacterial strains in fleas did not match those found in their hosts [155]. 
Similar results were observed in another study where rodent fleas removed 
from bacteremic hosts were infected with both host strains and other strains 
[160]. In both these studies guts and ovaries dissected from fleas were 
positive for bartonella bacteria, supporting the potential for vertical 
transmission of some bartonella strains in fleas [155, 160].  
     The flea Xenopsylla ramesis has recently been shown to acquire midgut 
infections with bartonella strains circulating in its natural rodent host [153]. 
Bacterial transmission by the flea was not assessed. Testing of eggs laid by 
females feeding on bacteremic hosts revealed no evidence for bacterial 
transmission to offspring [153]. Both eggs and larval developmental stages 
tested negative for the presence of bacterial DNA [153]. Though there 
appears to be a conflict in evidence for vertical transmission of bartonellae in 
fleas, different flea species were investigated in these studies so the potential 
for vertical transmission of bacterial strains in fleas should not be ruled out. 
EPIDEMIOLOGY OF HUMAN BARTONELLA INFECTIONS 
     Over the last decade bartonellae have repeatedly emerged or re-emerged 
as a cause of human illness globally [43, 163-168]. Infections with these 




animals or from hematophagous arthropods [169]. In some cases the source 
of infection is unknown though presumed to be a mammalian reservoir or an 
arthropod vector [43, 164, 165, 170]. Either immunocompetent or 
immunocompromised people may become ill due to bartonella infections 
[171]. The two Bartonella species most commonly recognized as causing 
human illness are B. henselae, the agent of ‘cat scratch disease’, and B. 
quintana which caused numerous cases of trench fever in soldiers during 
World War I. Bartonella quintana is considered a re-emerging infectious 
disease as the incidence of infection with this bacterium is increasing in 
human populations not previously recognized at risk for disease [105]. This 
includes homeless people and alcoholics who have higher intrinsic risk for 
louse parasitism and depressed immune function, both factors that can 
enhance their susceptibility to infection [166, 172, 173]. In South America, 
the lesser known though more virulent B. bacilliformis causes Carrion’s 
disease in humans [105]. Carrion’s disease refers to either the acute illness 
caused by this bacterium, known as Oroya fever, and/or a second stage 
chronic syndrome known as verruga peruana. During Oroya fever,  infected 
patients may develop a severe, life-threatening hemolytic anemia [105, 
172]. Human bacteremias are commonly only observed during infection with 
B. bacilliformis and B. quintana, the human pathogens, and may or may not 
be accompanied by clinical disease [105].         
     With respect to the zoonotic bartonellae over 22,000 cases of human 
infection with B. henselae, the ‘cat scratch disease’ agent, are reported 




other zoonotically acquired bartonellae infections, both in the United States 
and on a global scale, has yet to be fully determined. Humans infected with 
zoonotic bartonellae can present with long term headache, myalgia, 
lymphadenitis, neuroretinitis, bacillary angiomatosis, hepatic peliosis, 
meningitis, myocarditis, and endocarditis [106, 169, 174]. While infection of 
incidental hosts with zoonotic bartonellae can result in disease, these 
bacteria do not normally cause morbidity in their natural hosts [109, 175].  
     Bartonella henselae is the most studied species among the zoonotic 
bartonella in terms of experimental in vivo and in vitro studies [106, 169, 
176]. It is maintained in a feline reservoir (domestic and wild felids) and is 
transmitted from cats to humans most often by a cat scratch, though some 
human patients with the disease deny contact with cats [176]. Patients 
sometimes report arthropod bites, which suggests that some ‘cat scratch 
disease’ cases may be acquired from infected arthropod vectors. Considering 
that flea bites constitute the primary mechanism for transmission of B. 
henselae among cats, it’s probably that people can also be infected this way 
[147]. 
     Zoonotic bartonella infections are considered to be emerging infectious 
diseases because improved surveillance and diagnostics have allowed 
infections to be detected in populations not previously recognized to have 
them [30, 165, 177-180]. Infections acquired from peridomestic or 
commensal small mammals seem to occur at low incidence but this may be 
due to the inherent difficulties in diagnosing these infections [39, 165, 167, 




low levels of bacteremia in incidentally infected hosts makes detection of this 
agent complex. Bacterial isolation from incidental host blood is uncommon 
and though tissues and blood are often cultured in attempts to obtain an 
isolate, these methods are not often successful [165, 171, 182]. Species 
specific PCR assays and serological tests such as immuno-fluorescent assays, 
with four-fold changes in titer between acute and convalescent sera, are 
often relied upon to diagnose infections [171, 177, 178].  
     As zoonotic bartonella infections become more prevalent, the need to 
understand the transmission dynamics of the bacteria among its natural 
hosts and to incidental hosts has intensified. Whenever possible human cases 
have been followed up with epidemiological risk assessments of behavior and 
environment [39, 44, 164, 165, 171]. A consistently identified risk factor is a 
history of direct and indirect exposure to wild and domestic animals including 
arthropod vectors [165, 183]. Still, specific exposure events leading to 
infection are not often identified [44, 168, 171] (Table 1.2).  
     In 2008 a woman with a recent history of disposing of dead rodents was 
diagnosed with meningitis caused by a B. washoensis-like bacteria [167]. 
Fleas (Oropsylla wagneri) collected from rodent burrows and a California 
ground squirrel captured on her property were tested and found to contain 
bacteria genetically identical to the strain infecting her [167]. Whether she 
acquired the infection from a flea bite or rodent contact was never 
definitively determined [167]. In France in the last five years, three non-
related cases of B. alsatica infection have been reported [168, 184]. One 




three patients had handled rabbits, either butchering or rearing the animals 
[168, 184, 185]. In another instance candidatus B. melophagi was isolated 
from two chronically ill patients [44]. The bacterium was originally isolated 
from sheep and sheep keds. Again, specific exposures leading to patient 
infection could not be determined [44]. Because patients infected with 
zoonotic bartonella often have complex histories of animal and arthropod 
contacts, it is difficult to satisfactorily assess and quantify the risk of 
acquiring zoonotic bartonellae infections. This is due to a fundamental lack of 
understanding as to whether risk occurs in the context of animal and/or 
ectoparasite contact, and what type or how frequent such contact must be to 
constitute a risk.  
Human infections with zoonotic bartonellae 
      Case reports of human infections with zoonotic bartonellae are 
summarized in Table 1.2 (n = 21). Human bartonella infections with species 
associated with domestic companion animals are not included in the table (B. 
henselae, B. clarridgeiae, B. koehlerae, B. vinsonii subsp. berkhoffi). Criteria 
for inclusion in the table were publication in English and individually reported 
patient data (not summary data for groups of infected patients).  
     Patients infected with zoonotic bartonellae can present with a wide variety 
of symptoms (Table 1.2). Symptoms can be quite severe leading patients to 
seek medical interventions.  Some patients reported illness for up to two 
years prior to diagnosis of infection: others reported acute onsets that could 
sometimes be linked to potential exposures (Table 1.2, raccoon bite, travel 






Table 1.2 Epidemiological and clinical features of cases of human zoonotic bartonella infection. [yo = years old, NR 
= Not reported, IFA = Immunofluorescent antibody assay, IHC = Immunohistochemistry, MIF = Micro-
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those patients >50 years old. Eleven of 21 cases were reported in males (age 
range 12—86 years old), and 10 were reported in females (age range 20—79  
years old). Most patients were treated for weeks to months with antibiotics, 
usually aminoglycosides, and most or all symptoms seemed to resolve 
following treatments [191, 192]. Cases were reported from the United 
States, France, United Kingdom, the Netherlands, Russia, and Thailand 
(Table 1.2).  
     Co-morbidities were reported for seven patients ranging from heart valve 
replacements to diabetes mellitus (Table 1.2). Thirteen patients had no co-
morbidities reported, and one patient was reported as not having any co-
morbidities. Some patients had high occupational rates of animal exposure 
over time; others denied contact with animals or reported limited exposures 
to animals not known to harbor the strains infecting patients (Table 1.2). 
Exposures to arthropods were variable. Pet ownership was inconsistently 
reported. Epidemiological risk reporting varied widely in these reports and it 
is not apparent what risk factors were assessed for several cases as only 
positive exposures were reported (Table 1.2).  
     Bacteria were isolated from 12 of the 21 patients (Table 1.2). In the other 
cases blood cultures were either not attempted, were negative, were 
probably not incubated long enough to grow Bartonella spp., or were 
obtained after patients began antibiotic treatment. In the absence of 
bacterial isolation from blood, cases were confirmed by PCR detection of 
bartonella DNA in tissue, by serum IFA or Western blot, by IHC of cardiac 




     Recently zoonotic Bartonella species infections were reported from a 
group of Thai patients with febrile illnesses [165]. Bartonella species DNA 
was identified in 14/261 screened samples (7.7%). Half the bacterial strains 
detected were genetically related to rodent-associated Bartonella species 
(7/14), four sequences were novel, one was B. tamiae, and two were B. 
henselae. Patients reported owning animals (10/14) and more than half 
reported exposure to rats within 2 weeks of illness onset (8/14). 
Symptomatology associated with their illnesses is consistent with 
symptomatology for febrile illness cases in Table 1.2 [165]. 
Seroprevalence surveys for human exposures to zoonotic bartonellae 
    Reports of 13 seroprevalence surveys using antigens derived from rodent-
associated and other Bartonella species were identified (English language, 
PubMed and Web of Knowledge) [177, 183, 193-203]. Five surveys were 
conducted in Sweden, five in the United States, two in Thailand and one in 
the Democratic Republic of Congo (DRC). Antibody prevalences to B. 
henselae, B. elizabethae, and B. quintana were assessed in all 13 studies. 
Additional Bartonella species on the IFA assay panels represent strains 
circulating in animal reservoirs in areas where these surveys were conducted, 
and which humans might potentially come in contact with.   
     Patient sera from serious febrile illness cases in the Four Corners area of 
the U.S. were screened against 9 bartonella strains [203]. These included B. 
henselae, B. elizabethae, and B. quintana, and strains from deer mice, cotton 
rats, meadow voles, white-throated woodrats, rock squirrels, and Ord 




associated Bartonella species, seemingly dominated by responses to the 
woodrat strain antigen, though extensive cross-reactivity between strains 
made interpretations of results difficult [203].  
     In Sweden antibody to B. grahamii was observed following the addition 
antigens from the rodent-associated species B. grahamii and B. vinsonii 
subsp. vinsonii to the IFA panels. Recent serosurveys in Thailand included B. 
vinsonii subsp. vinsonii antigens [177, 202], and it is expected that 
additional antigens will be added to future panels consistent with strains 
detected in febrile illness patients (discussed above, also Table 1.2) [30, 
165]. Antigens from six Bartonella species (B. henselae, B. elizabethae, B. 
quintana, B. vinsonii subsp. vinsonii, B. vinsonii subsp. arupensis, B. 
clarridgeiae) were used for IFA assay of sera obtained from febrile patients in 
the DRC [201]. Patients were most reactive to B. clarridgeiae in that study, 
and no antibody to rodent-associated strains was observed [201].  
     Most of these 13 serosurveys were conducted in populations that might 
be expected to have a high risk of bartonella exposure except for two in 
Sweden that involved healthy blood donors [193, 195]. Populations sampled 
included cases of chronic fatigue syndrome [199], homeless and intravenous 
drug users [194, 196-198, 200], febrile illness patients [177, 201-203], and 
cases where bartonella exposure was suspected [183, 193]. Seroprevalence 
to rodent-associated bartonella strains was the dominant finding, with rates 
ranging from 4% to 52.1% for studies positive for this response (12/13). In 
10 studies the highest antibody prevalence rates observed were to B. 




between strains due to cross-reactivity [177, 203], and the DRC study 
reported no patient antibody responses to B. elizabethae antigen [201].  
     Results from serosurveys suggest that exposures to rodent-associated 
bartonellae are common in some human populations. Blood donor surveys 
revealed antibody to B. elizabethae in 4% (n = 100 samples) and 14.1% (n 
= 498) of healthy Swedish adults screened (cutoff titer 1:64), further 
suggesting that exposures occur commonly among some general human 
populations as well [193, 195]. The disparity between number of diagnosed 
human infections with zoonotic bartonellae and serosurvey results is marked 
(Table 1.2). This highlights several important features of these infections. 
Detection of infection in patients can only occur if diagnostic assays are 
applied with reasonable suspicion of Bartonella species involvement in the 
illness. Blood cultures must often be incubated for extensive periods of time 
before growth will appear [30]. PCR and IFA assays and IHC are specific for 
detection of these micro-organisms. If bartonellae are not suspected as a 
cause of illnesses samples will not be screened by these methods. In 
addition, though cross-reactivity among Bartonella spp. appears common in 
IFA assays, appropriate antigens should be used to assess infection and 
exposure rates in different populations. Successful detection of bartonella 
infections in humans is based on knowledge of the environment, what animal 
reservoirs are present in a location and which strains are circulating there. 
This information can often raise the index of suspicion for bartonella 




     Bartonellae infections in humans are likely under-recognized and under-
reported. The human disease burden due to infections with these bacteria 
may be much higher than previously believed. As surveillance efforts improve 
and diagnostic techniques become more sensitive and specific we can expect 
to better define the incidence and prevalence of bartonelloses in human 
populations.  
LABORATORY MOUSE MODELS FOR BARTONELLA INFECTION 
     Bacteria in the family Bartonellaceae are aptly described as stealth 
pathogens [205]. They are increasingly associated with zoonotic infections 
worldwide, creating more awareness of them as infectious agents of 
emerging public health concern [169, 174]. The morbidity associated with 
these illnesses and the bacteria’s insidious tendency to infect some of the 
most vulnerable and resource challenged human populations in the world is 
slowly drawing attention (Table 1.2) [165, 169, 174, 177, 183, 193-203]. 
Even in more developed countries we have evidence of an impact of the 
bacteria. In the modern world we have both the drive and resources to 
pursue understanding of infectious agents and their mechanisms of 
persistence and virulence. Yet our ability to investigate these pathogens is 
being challenged in one of the most basic research areas in modern science. 
Almost one hundred years after the first attempts were made to model 
bartonelloses in animal models there remain significant impediments to the 
development of disease models for these bacteria [206].   
     Animal models for bartonella bacteria induced diseases, especially mouse 




simply fail to become infected following inoculation with most Bartonella 
species (Table 1.3) [145, 207]. Though they may develop pathology 
following exposures, it does not typically match characteristics of human 
infections or pathology [208-210]. Failure of bacteria to infect mice is most 
probably due to host specificity and seems to be a nearly universal feature of 
these species.  
     Though zoonotic bartonellae that infect humans have already successfully 
accomplished one host switch this does not seem to translate to host 
promiscuity. A prime example of this is seen with strains of B. henselae 
isolated from both cats and infected humans. Neither strain type will infect 
mice and produce bacteremia [211].   
     Mouse models for human disease caused by B. bacilliformis and B. 
quintana have never been developed. A series of experimental infection 
studies using non-human primates in the 1920’s demonstrated that B. 
bacilliformis was the causative agent of Carrion’s disease [212-215]. It was 
not until the 1960’s that Koch’s postulates were satisfied with regards to B. 
quintana. Bacteria were isolated on blood agar plates from clinically ill 
patients and used to infect other human volunteers [216, 217]. The outcome 
of the studies proved the bacterium was the agent of trench fever.  
     Studies investigating Bartonella species interactions with host cells have 
been done almost exclusively in vitro. Such studies are useful for evaluating 
the role of specific genes, immune cells, or bacterial effector proteins in host 




for, nor duplicate whole organism responses to infectious bacteria [63, 64, 
92, 211, 220, 221].  
     Attempts have been made to develop in vivo models for studying 
bacterial interactions and mechanisms of pathogenesis but the vast majority 
of outcomes were unsuccessful. Published reports of laboratory mouse 
models for bartonella infection are summarized in Table 1.3. Of particular 
note are the numerous laboratory mouse stocks/strains used in these 
evaluations as well as the routes of exposure employed [222-224]. Mouse 
models for bartonella infection would have the advantage of the widespread 
availability of murine immunological reagents and selective mutant strains of 
mice for investigating specific questions about bacteria-host cell interactions. 
     Models for immune response elicited against B. henselae dominate this 
group and kinetics of antibody response and aspects of cellular and humoral 
immunity have been determined (Table 1.3). The problem is that the mice 
typically clear the inoculated bacteria within hours to a few days, so these 
models are not suitable for investigating bacterial interactions with host cells. 
Mice can develop granulomatous lesions in their livers following inoculation of 
B. henselae but unlike in human ‘cat scratch disease’ cases these lesions are 
neither necrotic nor suppurative [210, 220].       
     Mice with all manner of genetic defects in immune response have been 







Table 1.3 Numerous inbred and outbred mouse stocks have been experimentally infected with Bartonella species in attempts to 
reproduce bacteria-host cell interactions observed during natural and incidental host infections. [IP = intraperitoneal, ID = 
intradermal, PO = per os (oral), IV = intravenous, SQ = subcutaneous] 
 








outcome Actual outcome Ref. 
B. henselae  
(6 clinical isolates) 
B. quintana  







Species specific antibodies, 
intraspecies cross reactivity [225] 









Negative blood culture, 
serum IFA and pathology [226] 






granulomas Granulomatous inflammation [210] 
























/-); immune response [85] 

















Table 1.3 continued. 
 








outcome Actual outcome Ref. 








Persistent liver inflammation 
(20 weeks); cell mediated 








IV, IP, ID 






Liver and spleen pathology, 
granulomas (1 
immunocompetent mouse); 
ultrastructural changes in 
bacteria [229] 







response; role of 
T-cells 




B. bacilliformis (patient 
isolate IMTAVH#00032) BALB/c 
10-12 
weeks 






No bacteremia, no 
granulomatous lesions; liver 
abscesses one inoculated 
mouse and one control 
mouse; no other 
histopathology [231] 







Spleen cells produced IFN-γ, 











Table 1.3 continued. 
 








outcome Actual outcome Ref. 
B. henselae Fr98/K8 
B. henselae Fr98/K8aM 


































(up to11 weeks duration) 
[233] 
BALB/c 
3 & 18 
months 
IV 
B. birtlesii M39 
B. birtlesii P63 
B. birtlesii Q73 
B. doshiae C26 
B. doshiae MAC35 
B. doshiae R18 
B. doshiae 70WNH 
B. grahamii F16 
B. grahamii R16 
B. grahamii 33TD 
B. taylorii LL-WM9 
B. taylorii MAC36 




















attempts to recreate human disease pathologies (Table 1.3) 
[www.informatics.jax.org]. Immunocompromised, bartonella infected 
patients are the only recognized human patient population that consistently 
develops bacteremias during zoonotic bartonella infections. Antibody 
responses during incidental host infection with accompanying bacteremia 
were determined in immunocompetent and immunodeficient mice using B. 
grahamii, a species originally isolated from Apodemus mice [85]. This 
provided insight into what antibody subclasses were involved in sterilizing 
immunity in contrast with responses lacking in immunodeficient mice.  
     There is intense interest in developing a mouse model for the unique 
vasoproliferative lesions associated with some Bartonella species infections 
[209, 219, 221, 234]. Models for endocarditis, myocarditis, neuroretinitis, 
and lymphadenitis would be invaluable for studying virulence mechanisms 
and bacterial trafficking and tissue distribution during incidental host 
infections. Defined in vivo systems would be useful in determining 
mechanisms of microbial pathogenesis such as the role of the T4SSs. 
     Mice have also been evaluated for use as models of natural host infection. 
Bartonella birtlesii can infect mice and produce bacteremia but this bacterium 
also adversely effected reproductive function of mice and should be viewed 
with caution as representing a natural host infection model [227, 235]. In 
addition, mice infected with this strain demonstrate bacteremias of only 8-11 
weeks duration, which is short relative to duration of persistent bacteremia 
observed in naturally infected rodent reservoir hosts [109, 111, 112, 115, 




was susceptible to infection with low bacterial doses would be an excellent 
candidate for vector transmission studies of bartonellae. Such a model would 
also be suitable for answering questions about the natural history of 
bartonellae in reservoir animals. This could include investigating the 
dynamics of host co-infection and the immunological responses involved in 
successive infections with different bacterial strains.  
     The Bartonella Laboratory at the Division of Vector-Borne Diseases in Fort 
Collins, CO has an extensive collection of bartonella strains obtained from 
wildlife from around the world. A unique opportunity exists there to assay 
strains from diverse animals in mice and to potentially develop models that 
better reproduce desired characteristics of bartonella infection, whether it be 
recapitulating dynamics of natural host infection, or reproducing human 
disease states. To this end strains were selected for experimental infection 
studies in mice based on 1) their host of origin, 2) their relatedness to known 
human pathogenic species, 3) their epidemiological significance in terms of 
human exposure risk, and 4) their isolation from ill humans and presumptive 
assignment of causality for that illness. Strains were to be inoculated into 
both outbred and inbred mouse stocks so all possible heterogeneity in 
response to infection could be captured. Specific aims were to develop mouse 
models for persistent bacteremia, bacterial host specificity, bacterial host 
switching, and bartonella induced pathogenesis. If desired outcomes of 
bacteremia or disease were observed, the study results could be published 
and serve as a resource for investigators interested in pursuing research in 






EXPERIMENTAL INFECTION OF LABORATORY MICE WITH 
BARTONELLA STRAINS FROM WILD MUS SPECIES: A HOMOLOGOUS 
HOST-BACTERIA MODEL SYSTEM AT THE GENUS LEVEL 
 
INTRODUCTION 
     The natural history of bartonella bacteria is not well understood nor has it 
been widely investigated. Many wildlife species act as reservoirs for diverse 
bartonella strains. Rodents in particular harbor numerous bartonella strains 
and species which appear to be exceedingly well adapted to their hosts 
[108]. Though longitudinal field studies provide insight into rodent population 
infection incidence and prevalence,  the dynamics of infection and 
transmission in rodent-bartonellae systems remain obscure. Vector 
transmission of several Bartonella species has been experimentally 
demonstrated but alternate transmission mechanisms have not been 
investigated for rodent bartonella strains. Evidence that vertical transmission 
may play a part in natural maintenance cycles of cotton rat and deer mouse 
strains was reported when fetuses and neonates of these species were found 




a possible mechanism for environmental transmission of bartonella bacteria 
[157]. 
     No studies have been published describing experimental infection of 
laboratory mice  with bartonellae isolated from Mus species in nature. To 
better understand bartonella infection and transmission dynamics in natural 
hosts it would be desirable to develop a model system that pairs a natural 
host with its co-adapted bartonella bacteria. As Mus musculus is the 
definitive laboratory animal model, a system comprised of the laboratory 
mouse and a co-adapted bartonella would have great utility for research 
purposes. To date, the well documented host specificity of bartonellae has 
been an impediment to developing such a model [145, 226, 231].  
     With an overall goal of obtaining insight into the natural history of rodent-
bartonellae systems, we designed a study to evaluate the in vivo infection 
characteristics of two Mus species bartonella strains in laboratory mice. 
Specific goals for the study were to observe 1) whether CD1 (ICR) mice (M. 
musculus) would be susceptible to infection with Mus species bartonella 
strains, 2) the response following inoculation of a range of bacterial doses, 3) 
bacteremia duration and magnitude in infected mice, and 4) whether viable 
bacteria might be present in bacteremic mouse urine. Since these strains 
were originally obtained from wild-caught Mus species (M. caroli and M. 
cervicolor) we thought it likely the bacteria could successfully switch from 
one Mus species to another, i.e. to M. musculus. Host-specificity of rodent 
bartonellae has been previously demonstrated at the genus level but not at 




characteristics of naturally acquired bartonella infections would be desirable 
for investigating bacteria-host interactions such as persistent bacteremia and 
bacterial host specificity, and whether vector transmission of bartonellae 
among hosts is important for the maintenance of these bacteria in nature.  
MATERIALS AND METHODS 
Mice and bacteria 
     Specific pathogen free, eight week old CD1 female mice were obtained 
from the closed, outbred mouse colony at the Division of Vector-Borne 
Diseases (DVBD), Fort Collins, Colorado, USA. Mice were housed six to a 
cage and groups were segregated based on strain identity and dose for the 
study duration of 27 weeks. All work with the mice was approved by and 
conducted under the supervision of DVBD’s Institutional Animal Care and Use 
Committee (IACUC) in accordance with United States Public Health Service 
(USPHS) standards for the humane care of laboratory animals (protocol #07-
004).   
     Source and passage history information for the study strains is detailed in 
Table 2.1 and does not include growth of stock for this study. Though the 
two strains have identical nucleotide sequence identities for their citrate 
synthase genes both were included in the study as they differed in host of 
origin. Bacterial stocks were grown on heart infusion agar plates (HIA) 
supplemented with 5% rabbit blood. Plates were inoculated to produce 
bacterial lawns and placed in a CO2 incubator at 35°C for 5 days at which 
time the bacteria were harvested in physiological saline. Stocks diluted in 




concentrations were calculated by thawing frozen stock aliquots, diluting 
them 10-fold and inoculating them onto plates as described above to 
enumerate colony forming units (cfu).  
  
Table 2.1 The Bartonella strains used in the study were originally isolated 
from Mus species in Thailand. 
 
Rodent source 
of strain Label Passage history (n = number of passages) 
Mus caroli  
(Ryukyu mouse) MA 
blood sample→ HIA + 10% rabbit blood, n=2;  
BHI + 10% rabbit blood1, n=2;  
Swiss Webster mouse2 (in vivo), n=1;  
BHI + 10% rabbit blood, n=1 
Mus cervicolor  
(fawn colored 
mouse) ME 
blood sample→ HIA + 10% rabbit blood, n=2;  
BHI + 10% rabbit blood, n=2;  
Swiss Webster mouse1 (in vivo), n=1;  
BHI + 10% rabbit blood, n=1 
 
1 Brain and Heart Infusion agar 
2 Swiss Webster mouse subcutaneously inoculated with 107 cfu. 
 
Experimental design and blood collections 
     Thirty-six mice were used to evaluate the two strains. Three groups of six 
mice were each subcutaneously inoculated with a different dose of bacteria: 
10, 100, or 1000 cfu, for each of the two bacterial strains (n = 18 mice X 2 
strains = 36). Bacterial doses were diluted in physiological saline and mice 
were inoculated in the dorsal midline between the scapulae. Blood was 
collected from each mouse weekly for 27 weeks. Sample volumes ranged 
from 80—125µl depending on mouse body mass. Blood was collected by 
lancet puncture of the submandibular vessel plexus while mice were 




administered intraperitoneally). The cheek of a mouse was first shaved and 
cleansed with chlorhexidine to create an aseptic site for blood collection. The 
puncture site was alternated weekly. Following blood collections mice were 
administered the anesthetic reversal agent atipamazole (5mg/kg 
intraperitoneally). Blood was frozen at -80°C until thawed for microbiological 
testing.  
     We observed a high mouse mortality rate during this study [6/36 (17%)], 
an unprecedented number in our experience working with mice. It was later 
learned that the ketamine used in our anesthesia cocktail was recalled due to 
an unduly high number of adverse events including deaths related to its use 
(Teva Animal Health, 2009). Three MA10, one MA100, one ME10, and one 
ME100 mouse died between study weeks 4 and 15. Available bacteremia 
data for these mice is presented in the results section. 
Urine collections 
     Urine was collected from mice weekly for 4 weeks (weeks 3—6) by 
manual expression beginning soon after mice began manifesting bacteremia. 
While mice were anesthetized for blood collection the bladder was gently 
squeezed and any urine expressed was captured in a sterile tube. 
Cystocentesis was not performed to preclude the possibility of lacerating 
blood vessels during urine collection, thus contaminating the sample with 
blood. Urines were frozen at -80°C until thawed for microbiological plating. 
Attempts were made to collect urine from all mice in the study but some 
mice voided during handling prior to anesthesia induction. Collection volumes 




80µl per mouse. On a weekly basis urine was collected from 73-100% of 
mice.  
Testing samples for viable bartonella bacteria 
     Frozen whole blood was thawed and mixed (50µl + 50µl) with brain heart 
infusion (BHI) diluent containing 15µg/ml Fungizone™. The resultant 100µl 
samples were inoculated onto HIA plates supplemented with 5% rabbit blood 
and incubated for up to 2 weeks at 35°C in a 5% CO2 atmosphere. Samples 
with colonies too numerous to count were subsequently diluted so cfu could 
be counted and bacteremia levels could be calculated. Colonies were 
confirmed as bartonella by Gram stain and  colony morphology (either rough 
or smooth) [236].  
     Urine samples were thawed and 50µl of each sample was mixed with BHI 
diluent containing 20µg/ml Fungizone™. When sample volume was less than 
50µl all available urine was used for plating. Diluted samples were inoculated 
onto HIA plates supplemented with 5% rabbit blood and held for up to two 
weeks at 35°C in a 5% CO2 incubator.  
RESULTS 
Bacteremia kinetics in mice 
     Mice were susceptible to infection with both bartonella strains evaluated 
and displayed a dose dependent response to both with 56—75% of mice 
becoming bacteremic (12/18 MA and 11/18 ME, respectively) (Table 2.1, 
Figures 2.1A-E). Mice inoculated with the 1000 cfu dose of MA manifested 





















Average time to 
bacteremia onset  







study end  
(Week 27)  
MA (10) 3/6  1 X 10
2 – 8.5 X 106 12 [11—14] 10—13 0 
MA (100) 3/6 1 X 10
2 – 1.1 X 107 9.6 [3—19] 8—20 2 
MA (1000) 5/6 1 X 10
2 – 4.2 X 107 5 [1—17] 10—25 4 
ME (10) 0/6 None None None 0 
ME (100) 4/6 1 X 10
2 – 2.7 X 106 12.2 [6—18] 6—16 2 
ME (1000) 6/6 1 X 10
2 – 9.4 X 106 11 [6—18] 6—13 0 
 
1 eight mice were still bacteremic when the study was terminated: duration of bacteremia data is therefore 




of at least 5—6 weeks occurred before any mouse manifested bacteremia 
with ME regardless of dose. It should be noted that mice that died apparently 
uninfected might have manifested late onset bacteremias had they survived 
(n = 4/6; the other two mice were already bacteremic). (Figures 2.1A-E, 
Table 2.2).  
     Bacteremia duration in some individual mice was months long. We 
defined the duration as the time from first manifestation of bacteremia till 
last bacteremic observation or till the end of the study. This was regardless 
of whether bacteremia was detected at all weeks between onset and 
termination. Some mice displayed abacteremic intervals where high 
bacteremia levels were followed by periods without detectable bacteremia 
after which bacteremia was once again detected (Figures 2.1A-E). 
Abacteremic intervals were often associated with an overall pattern of 
decreasing bacteremia levels (Figures 2.1A-E).  
     Inoculated mice in both groups showed variability in time to bacteremia 
onset. (Figures 2.1A-E, Table 2.2). This response was especially evident in 
both strain groups at lower doses (10 or 100 cfu) where temporal lags in 
manifestation of detectable bacteremia ranged from several weeks to months 
for mice within the same dose group. Some mice were still bacteremic when 






Figure 2.1A. Bacteremia kinetics for CD1 mice inoculated with strain MA (10 





Figure 2.1B. Bacteremia kinetics for CD1 mice inoculated with strain MA (100 






Figure 2.1C. Bacteremia kinetics for CD1 mice inoculated with strain MA 






Figure 2.1D. Bacteremia kinetics for CD1 mice inoculated with strain ME (100 






Figure 2.1E. Bacteremia kinetics for CD1 mice inoculated with strain ME 




Bacteria in urine 
     During the 4 week collection period urine samples were collected at least 
three times from all mice in both strain groups. No bartonella bacteria were 
detected in the mouse urines by microbiological plating and plates inoculated 
with urine displayed little or no contamination that might have interfered 
with our ability to detect bartonella bacterial growth.   
DISCUSSION 
     This is the first report of experimental infection of laboratory mice with 
bartonella strains obtained from Mus species in nature and represents a 
homologous host-bacteria system at the genus level. These bacterial strains 




laboratory mouse. Persistent bacteremia was observed following low dose 
exposures in a high proportion of inoculated mice. Infected laboratory mice 
manifested high level, long duration bacteremias with abacteremic intervals 
reproducing characteristics of infection reported for natural reservoirs of 
rodent bartonella strains [109, 111, 115].  
     Longitudinal field studies looking at field voles in the UK, cotton rats in 
Georgia, USA, and deer mice in Colorado, USA have documented bacteremias 
from several months to a year duration in naturally infected rodents [109, 
111, 112]. Bacteremia levels reported for naturally infected rodent hosts 
range from 106 cfu/ml for bartonella strains infecting Sigmodon hispidus 
(cotton rats) [112], to levels of 105 cfu/ml in Rattus spp. [137], to 104 cfu/ml 
in Neotoma spp. (woodrats) [140] and Cynomys ludovicianus (black-tailed 
prairie dogs) [144].   
     Mice in our study exhibited high sustained levels of bacteremia following 
low dose exposures and represent the first immunocompetent mouse model 
to replicate the longevity of bartonella bacteremia well beyond 11 weeks. 
Two other laboratory mouse models for persistent bacteremia [85, 227, 235] 
have been reported. The more extensively investigated of the two used a 
strain of B. birtlesii originally isolated from Apodemus species [227, 235]. 
Laboratory mice infected with this strain manifest bacteremias up to 10 
weeks duration with levels of bacteria in the blood up to 105 cfu/ml [227, 
235]. Similarly, immunocompetent mice inoculated intravenously with 109 
cfu of B. grahamii developed bacteremias up to 104 cfu/ml and 11 weeks 




infection kinetics, such as truncated or low level bacteremias even following 
high dose bacterial exposures are probably due to sub-optimal levels of 
bacterial adaptation to an alternate host.        
     Temporal lags in bacteremia onset associated with different dose 
exposures were commonly observed during this study. The dynamics of 
response seemed to be primarily influenced by the dose inoculated, where 
lower doses generally seem to elicit a shorter duration bacteremia of 
somewhat lower level (Figures 2.1A-E, Table 2.2). Lags before bacteremia 
onset following bacterial exposure may be a common characteristic of natural 
infections, and may complicate attempts to define the transmission dynamics 
of rodent bartonella strains among their hosts. There is evidence that 
bartonella bacteria are transmitted by fleas [147, 150], yet analyses of data 
collected during longitudinal field studies of bartonella infected rodent 
communities have generally failed to find correlations between flea 
abundance, flea infection rates, and rodent host infestation rates or infection 
prevalence [122, 140]. Incongruences among these parameters may be 
explained by our study results which demonstrate that rodent hosts can have 
an extremely variable response in time to onset of bacteremia (Table 2.2). 
Differences in exposure dose and individual variation in susceptibility to 
infection in rodent populations can complicate attempts to find correlations 
among these parameters.  
   Results of our study provide insight into the transmission dynamics of 
these strains in nature in two areas. First, susceptibility to infection at low 




these strains among mice or other rodents. Therefore, either hosts must 
become infected at low doses of the bacteria or transmission may occur via 
an as yet unproven mechanism of cumulative exposures. Indeed, it may be 
that both these criteria need be met for bartonellae transmission to occur. 
Since these bacteria tend to be co-adapted to their hosts, infection at low 
doses is probable, and likely, in natural reservoirs. Scenarios of cumulative 
exposure to the bacteria leading to infection are also  credible in that rodent 
fleas and their hosts often share a long association with fleas typically 
feeding upon their hosts one or more times a day. In addition, flea feces are 
routinely deposited in the fur of parasitized animals as well as in host 
burrows or nests, and could serve as a long-term exposure source to hosts 
as they have been shown to contain viable bartonellae.  
     The second area in which our observations may provide insight into the 
bacterial transmission dynamics is the observed dose dependent response. 
Mice in our experiments were susceptible to low dose inocula (10, 100, and 
1000 cfu) of bacteria. In the B. tribocorum-rat model of bacteremia 
intravenous inoculation of 107 cfu bacterial dose resulted in bacteremia onset 
in five days. When cotton rats were inoculated with low and high doses of 
cotton rat bartonella strains, they developed bacteremia within one week as 
well [145]. This suggests that in natural hosts bacteremia onset is initiated 
by some threshold dose. In those studies the threshold was met and the 
response was immediate. However, in those laboratory models and this one, 
putative natural mechanisms of arthropod transmission were not assessed. 




pathogen exposure commonly serve as surrogates in the laboratory for 
arthropod bites or scratching which results in self-inoculation of infectious 
materials such as flea feces. When attempting to reconstruct natural 
transmission mechanisms in the laboratory, a reduction in number of 
bacteria ultimately colonizing the host should be considered with respect to 
the simulated methods. For example, if bacteria must  invade the vasculature 
following deposition in the dermis then there is likely a reduction in the 
number of colonizing bacteria versus the number that were contained in the 
original exposure dose. Importantly, it might be expected that infection by 
such simulated exposure routes might take longer to develop than when 
viable bacteria are deposited directly into the bloodstream (intravenous 
route), or are placed in physiological compartments where the vasculature is 
more accessible to the bacteria (intraperitoneal or subcutaneous routes). 
Therefore intradermal inoculations or scarifications might be more likely to 
reveal candidates for vector transmission of the bacteria than other exposure 
routes. Strains evaluated in the current study would be excellent candidates 
for exploring whether a threshold dose for infection exists, if cumulative low 
dose exposures could result in infection, and whether there might be 
potential differences in infection response associated with different routes of 
bacterial exposure.   
     A high background of intra- and interspecific contacts exists in rodent 
inhabited ecosystems. Resource competition, partitioning, and sharing 
among rodents will occur frequently in such settings. Aggressive and 




between animals. In addition, nest or burrow sharing or opportunistic use of 
the same among rodents has been documented, which allows for yet more 
direct and indirect contacts between rodents. If susceptibility of mice to low 
doses of these strains reproduces susceptibility of natural rodent to 
bartonella infections, then it becomes more plausible that these types of 
contacts and/or arthropod vector exchanges between hosts can result in 
transmission of the bacteria.      
     Bartonella bacteria were not detected in the urine of infected mice during 
this study though mice were bacteremic at the time of sampling (weeks 3—6, 
Figures 2.1A-E). Since urines were only collected for 4 weeks it is possible 
that additional sampling might have revealed the presence of bacteria in the 
urine later in the study. However, in a previously published study urine 
collected from B. henselae infected, bacteremic cats was evaluated for the 
presence of viable bacteria or DNA without success [237]. This suggests that 
urinary excretion of bartonella bacteria is not common if it occurs at all. 
However, because the relationships between specific bartonellae and their 
natural hosts is still not well understood the possibility remains that this 
transmission mechanism could function in some natural reservoir 
populations. 
     The two Mus species bartonella strains evaluated in this study share 
100% nucleotide sequence identity for a portion of their citrate synthase 
gene (gltA), the gene most commonly used to evaluate genetic relatedness 
among bartonella strains and species, yet they exhibited different infection 




The simplest explanation is that this represents natural variability among 
these bacterial strains. Alternatively, clonal selection during isolation and 
microbiological plate passage may have resulted in expansion of a bacterial 
sub-population that displays differential characteristics from the parent 
population. This could have occurred with either or both isolates, and is 
always a possibility when bacteria are sampled from their natural 
environment and grown on microbiological media. Immune selection is also a 
possibility, since both of these isolates were passaged in mice. Finally, the 
differential infection phenotype may exist in nature and function to reduce 
competition for hosts between these phenotypic variants, but such an 
interaction would depend on a lack of cross-immunity between the strains.  
     Interestingly, strain MA appeared as rough colonies throughout the study 
when cultured from bacteremic mice, whereas cultured ME produced 
consistently smooth colonies with some rough colonies present at times. This 
phenomenon, termed phase variation, has been described from rodent 
bartonella isolates previously [236]. In addition, rough/smooth colony 
phenotypes have been investigated for B. henselae and the rough colony 
morphology was shown to be associated with the expression of pili [238]. A 
rough colony producing B. henselae strain was 100 times more invasive in 
vitro than a smooth colony producing B. henselae strain [238]. Increased 
expression of pili by strain MA relative to strain ME could also explain 
differences in their in vivo infectivity for the mice. 
 In summary we report on a mouse model for persistent bacteremia using 




used to evaluate the transmission dynamics of bartonella bacteria among 
hosts or to investigate the molecular basis for host specificity demonstrated 
by some bartonella strains. Susceptibility of mice to infection at low bacterial 
doses coupled with high bacteremia levels make this system a superior 
candidate for vector transmission studies. Finally, the dynamics of bacterial 
co-infection and host competition can be explored using both MA and ME in 







EXPERIMENTAL INFECTION OF LABORATORY MICE WITH RAT 
BARTONELLA STRAINS: HOST SPECIFICITY, BACTEREMIA KINETICS, 
DOSE DEPENDENT RESPONSE AND PATHOLOGY  
 
INTRODUCTION 
     Many bartonella strains have potential to cause disease in humans 
(Tables 1.1, 1,2 Chapter 1). It is important to understand the epidemiological 
and ecological risk factors associated with human acquisition of infection [44, 
106, 165, 167]. Some infected patients have histories of animal and 
arthropod contacts but others deny such exposures [44, 165, 171]. It is 
unknown what triggers some bartonella strains to perform what is essentially 
a host switch and infect a human incidental host. We know that some 
Bartonella species naturally cycle in a limited number of host species, 
whereas others may utilize animals from several genera within a taxon as 
natural reservoir hosts [33, 112, 122]. Perhaps bacterial host specificity 
could be a predictor for whether a bacterial strain might infect an incidental 
host. 
     Of all the wildlife that serve as reservoirs for bartonellae, rodents harbor 




agricultural settings throughout the world [239] and many rodent 
populations have high prevalences of bartonella infection [3, 136-138]. 
Infected rodents can also maintain bacteremias for long periods of time, 
often months, and fleas and other ectoparasites that might act as vectors are 
commonly found on rodents [112, 130, 239, 240]. These characteristics 
define a reservoir of bartonellae in nature that can pose a risk to human 
health.  
     Zoonotic disease agents that infect incidental hosts often possess an 
inherent capacity to infect a wide variety of mammalian hosts [241]. 
Evaluating the host specificity of high exposure risk bartonellae strains by 
simulating incidental host infections in the laboratory can provide a better 
understanding of a bacteria’s zoonotic potential [241]. To that end we 
designed a study to evaluate whether rat bartonella strains could infect the 
common laboratory mouse, M. musculus. Since rats and mice are members 
of different genera within the subfamily Murinae (Family Muridae, Old World 
mice and rats), we hypothesized that exposure of mice to rat bartonella 
strains could provide insight into 1) whether rat bacterial strains might 
demonstrate host specificity, 2) what proportion of incidental hosts might 
become infected following exposures at different bacterial doses, and 3) 
whether there might be pathology subsequent to infection. Importantly, 
bartonellae that seem able to utilize a broad host range may be more likely 
to successfully host switch, or ‘jump’ to incidental hosts [241]. The bartonella  
strains chosen for this study circulate in rat hosts in areas where humans 




MATERIALS AND METHODS 
Mice 
     The specific pathogen free, outbred Swiss Webster (SW) mice used in the 
experiments were obtained either from Taconic Farms (Germantown, NY), or 
from a SW mouse colony maintained at DVBD, Fort Collins, Colorado, USA. 
The SW mouse colony at DVBD was originally established with SW mice from 
Taconic Farms. Female mice 5—8 weeks of age were used for all experiments 
and were housed seven mice to a cage except control mice which were three 
to a cage. All work involving mice was conducted as outlined in our approved 
animal use protocol (#07-004), under the supervision of DVBD’s IACUC and 
in accordance with the USPHS standards for the humane care of laboratory 
animals. 
Bacteria 
     The low passage bacterial isolates used in this study were originally 
obtained from Rattus spp. in Asia (Figure 3.1, Table 3.1) [136, 137]. The 
four strains differ from one another either phylogenetically and/or with 
respect to their hosts of origin (Figure 3.1, Table 3.1). Strains Rl5132th, 
Rn1532yn, and Rf1563yn share ≥92.6% similarity by gltA (citrate synthase 
gene) sequence distance analysis [ClustalW algorithm, MegAlign, DNASTAR® 





















     Figure 3.1 This phylogram, based on a portion of the citrate synthase gene (gltA), illustrates the relatedness of the four    
     bartonella strains used in this study to one another and to other bartonellae isolated from Rattus spp. and other rodents  
     worldwide. For each strain/species included above we provide the GenBank accession number for the gltA sequence used,  
     and indicate the host and geographic location from which that strain was isolated. Four of the rodent associated Bartonella  
     spp. included in the tree are known to have caused human disease (*).  
Nucleotide Substitution per 100 residues 
0 2 4 6 8 10 12 
Rf1563yn [AF329679]; Rattus tanezumi subsp. flavipectus: China 
Rn1532yn [identical to AF075166, R. norvegicus, USA]; R. norvegicus: China 
B. elizabethae F9251 (Type strain) [Z70009]; Homo sapiens: USA* 
Bartonella genotype C7rat [Z70020]; R. norvegicus: Peru 
Rl5132th [AY269420]; R. losea: Thailand 
B. rattimassiliensis [AY515124]; R. norvegicus: France 
B. queenslandensis [EU111799]; R. tunneyi: Australia 
B. grahamii [Z70016]; Myodes (Clethrionomys) glareolus: UK* 
B. tribocorum [AJ005494]; R. norvegicus: France 
Bartonella genotype, Tel Aviv [AJ583111]; R. rattus: Israel 
B. birtlesii [AF204272]; Apodemus sp.: France 
Rn1691yn [AF363238]; Rattus norvegicus: China 
B. coopersplainensis [EU111803]; R. leucopus: Australia 
B. rattaustraliani [EU111794]; R. tunneyi: Australia 
B. washoensis [AF470616]; Spermophilus beecheyi: USA* 
B. phoceencis [AY515126]; R. norvegicus: France  
B. vinsonii [U28074]; Microtus pennsylvanicus: Canada* 




identity with the other three isolates, though it, like Rn1532yn, was obtained 
from a R. norvegicus in China (Figure 3.1). While the strains used in this 
study were obtained from rodents in Thailand and China, a BLAST nucleotide 
sequence query revealed that strains similar to these have been isolated 
from rodents worldwide [BLAST = Basic Local Alignment Search Tool, 
National Center for Biotechnology Information (NCBI), United States National 
Library of Medicine; gltA sequence; also Figure 3.1]. To construct the 
phylogram gltA sequences obtained from GenBank (NCBI) were edited to 
between 334—342 bp in length, aligned with MegAlign’s ClustalW, and the 
phylogenetic tree was generated [DNASTAR® Lasergene software, version 
8.1.2; all default parameters]. 
     Bacterial stocks for this study were prepared as described in Chapter 2. 
Stocks were held frozen at -80°C until used for mouse inoculations and the 
bacterial concentration of each stock suspension was determined as 
previously described (Chapter 2). Following mouse inoculations aliquots of 
each inoculum were inoculated onto HIA plates and bacterial concentrations 
were confirmed by colony growth and enumeration of colony forming units 
(cfu). 
Inoculation of mice and experimental design for the study 
     Seven groups of six mice were used to evaluate each of the four bacterial 
strains (Table 3.2), hereinafter referred to as ‘strain groups’. Each group 
within a strain group was inoculated with a different dose of bacteria ranging 
from 





Table 3.1 The four bartonella strains used in this study were originally 
isolated from Rattus spp. in Asia. The bacterial passage history follows the 
original isolation of the strains from blood and does not include growth of 
stock for this study. 
 
Strain  Rodent source  Strain origin 
Passage history  
(n = number of passages) 
Rn1691yn 
Rattus norvegicus  





BHI agar + 10% rabbit blood1, 
n = 2; BALB/c in vivo2, n=1;  
BHI agar + 10% rabbit blood,  
n = 1 
Rl5132th  
R. losea  





BHI agar + 10% rabbit blood,  
n = 4; BALB/c in vivo2, n=1;  
BHI agar + 10% rabbit blood,  
n = 1 
Rn1532yn 
R. norvegicus  
(Norway or  




BHI agar + 10% rabbit blood,  
n = 4; BALB/c in vivo2, n = 1;  
BHI agar + 10% rabbit blood,  
n = 1 
Rf1563yn 
R. tanezumi subsp. 
flavipectus 




BHI agar + 10% rabbit blood,  
n = 2; BALB/c in vivo2, n = 1; 
BHI agar + 10% rabbit blood,  
n = 1 
 
1 BHI = Brain and Heart Infusion 
2 Mice were inoculated with a divided dose of 107 cfu intraperitoneally and 
subcutaneously. 
 
cage of six experimentally inoculated mice to evaluate for environmental 
transmission of bacteria within the cage. Environmental transmission was 
defined as infection of a sentinel mouse resulting from contact with 
experimentally inoculated cage mates and/or their excreta. Sentinel mice 
were not inoculated, but shared cages with experimentally inoculated cage 
mates for the study duration. All experimental mice in the study were 
subcutaneously inoculated once along the dorsal midline between the 




each were subcutaneously inoculated with physiologic saline to serve as 
negative controls for each strain group (n = 4 negative control groups, three 
mice each). Negative control groups were inoculated and sampled on the 
same days as their experimental counterparts and were held separately from 
experimental mice for the study duration. 
 
Table 3.2 The experimental design for this study consisted of four strain 
groups. Each strain group contained experimentally inoculated mice, sentinel 
mice, and saline inoculated control mice. 
 
Bartonella 




No. mice  
in a  
strain group 
6 mice / dose 
group  
x 7 dose groups 
1 mouse / dose 
group  
x 7 dose groups 
3 mice / strain 
group  
42 7 3 52 
Total number of mice in the study  




     Blood was collected weekly from all mice in the study. Mice were 
anesthetized for all blood collections with a solution injected intraperitoneally 
(100 mg/kg ketamine + 50 mg/kg xylazine according to mouse body mass). 
Blood was collected in the manner described in Chapter 2, once a week for at 
least 13 weeks. Samples were stored at -80°C until tested for bacteremia. At 
the study endpoint(s) blood samples were collected from all mice by 





Testing for bacteremia 
     To evaluate mice for bacteremia frozen whole blood was thawed and 50μl 
was added to 150μl of diluent consisting of brain heart infusion supplemented 
with 15 µg/ml Fungizone™. Samples (100μl) were inoculated onto plates and 
incubated as described previously. Bacteremic samples were subsequently 
diluted (from 1:5 to 1:2500) to permit cfu counts so the bacterial 
concentration of the blood could be calculated. Colonies were confirmed as 
bartonella bacteria by morphology and Gram stain. 
Histopathology 
     Tissues were collected during necropsy 14 weeks post-inoculation from a 
subset of Rn1691yn infected mice. Heart, kidney, bladder, spleen, thymus, 
lung, liver, and lymph nodes (axillary, brachial, and inguinal) were harvested 
from surviving mice in the 106 and 107 cfu dose groups [n = 5 and n = 6, 
respectively], and fixed in 10% neutral buffered formalin. Matching tissues 
and organs were sampled from the three saline inoculated control mice. 
Following fixation all mouse tissues were subjected to standard processing 
and embedded in paraffin. Sections (5μm) were then stained with 
hematoxylin and eosin for evaluation by light microscopy (Colorado Histo-
Prep, Fort Collins, Colorado, USA). Photomicrographs were taken to illustrate 
immunopathological findings in experimental mice with reference to healthy, 
saline inoculated controls, and are representative of lesions in all affected 







Bacteremia in inoculated mice 
     Of the four bartonella strains evaluated in mice in this study, only one, 
Rn1691yn, produced bacteremia in mice (Figure 3.2A-D). For mice inoculated 
with 107 cfu of Rn1691yn, 6/6 (100%) became bacteremic with onset 
between 1 and 2 weeks post-inoculation (Figure 3.2A). Mouse #6 in this 
group had the greatest observed bacteremia level for any mouse in the 
study: 3 X 105 cfu/ml blood at week 2 post-inoculation, which was also when 
bacteremia was first observed. The other five mice in this dose group also 
manifested their greatest bacteremia levels at week 2 but only reached 104 
cfu/ml blood. Duration of detectable bacteremia for individual mice ranged 
from 4—8 weeks. 
     Five of six (86%) mice inoculated with 106 cfu of the Rn1691yn bacterial 
strain became bacteremic with onset between 1 and 2 weeks post-inoculation 
(Figure 3.2B). Mouse #5 manifested bacteremia at week 2 with 103 cfu/ml 
blood but then died of unknown causes the following week. Bacteremias for 
surviving mice ranged in duration from 5—7 weeks. The highest bacteremia 
observed in a mouse in this group was 104 cfu/ml blood. All surviving 
bacteremic mice (4/5) in the group also achieved this level by week 2 post-
inoculation. Mouse #3 had an abrupt drop in bacteremia at week 5 to below 
our level of detection; bacteremia was detectable again at week 6 and then 




in the 105 cfu dose group became bacteremic after inoculation (Figure 3.2C). 
Five of those six mice had bacteremia onset between 1—2 weeks post- 
 
Figure 3.2A. All six mice inoculated with 107 cfu of Rn1691yn developed 
bacteremia within 1—2 weeks post-inoculation.  
 
 
inoculation. Bacteremia duration in all six mice ranged from 5—7 weeks. 
Mouse #2 in this group achieved the second highest bacteremia level overall, 
2 X 105 cfu/ml blood. Mouse #1 in this group had bacteremia onset 8 weeks 
post-inoculation which was also the week of highest bacteremia for this 
mouse, 2.4 X 104 cfu/ml.  
     In the 104 cfu dose group, 3/6 (50%) mice became bacteremic following 




week 10 (Mouse #5). Bacteremia duration in the mice ranged from 3—7 
weeks. Mice manifesting bacteremia earlier had levels of 104 cfu/ml of blood, 
 
3.2B. Five of six mice inoculated with 106 cfu of Rn1691yn developed 
bacteremia. Mouse #5 died during week 3 so no additional data are available 
for her. 
 
whereas the highest bacteremia level for Mouse #5 was 7.8 X 103 cfu/ml. 
Bacteremia lasted only 3 weeks for Mouse #5, the shortest duration among 
mice that were monitored weekly. 
  The experiments evaluating infection of mice with strains Rl5132th, 
Rn1532yn, and Rf1563yn were terminated after 13 weeks as no mice in 
those groups had developed bacteremia. Mice inoculated with Rn1691yn 
were subject to two different outcomes. Rn1691yn mice in dose groups 104 – 




101—103 cfu were held an additional 16 weeks for observation for delayed 
 
Figure 3.2C. All six mice inoculated with 105 cfu of Rn1691yn developed 
bacteremia. Mouse #1 had no bacteremia at our level of detection until 8 
weeks post-inoculation. 
 
 bacteremia onset. Those mice had blood collected every 4 weeks for an 
additional four time points. Subsequently one mouse in the 103 cfu dose 
group was found to have a 7 X 102 cfu/ml bacteremia at week 17. Since 
blood was being collected monthly at this point bacteremia kinetics for this 
mouse are unknown excepting this single time point. 
     Mice in the other three strain groups had blood collected and tested 
weekly for 13 weeks. No bacteremia was detected in any of those 
experimentally inoculated mice at any inoculation dose. No sentinel (un-





Figure 3.2D. Three of six mice inoculated with 104 cfu of Rn1691yn became 
infected and developed bacteremias following inoculation.    
 
developed bacteremia from environmental (contact) transmission of the 
bacteria. In addition all blood samples collected from saline inoculated control 
mice were negative for bartonellae. 
Histopathological observations of mice inoculated with Rn1691yn 
     Multifocal granulomas with associated hepatic necrosis were observed in 
the livers of experimentally infected mice (5/5 mice, 106 dose group; 5/6 
mice, 107 dose group). These granulomatous nodules were usually seen in 
areas adjacent to or surrounding central veins [Figure 3.3A-B (Mouse #1, 107 
dose group)]. Single to multiple cell hepatocellular necrosis was also seen 




group)]. The livers of control mice were consistently unaffected [Figure 3.3D 
(Control mouse #2)]. Large granulomas were observed in the kidneys of 
experimentally infected mice (1/5 mice, 106 dose group; 3/6 mice, 107 dose 
group). These granulomas were only seen in the cortex, perivascularly, 
causing displacement of glomeruli and surrounding proximal tubules [Figure 
















Figure 3.3 Hematoxylin and eosin stained sections show granulomatous 
lesions in the livers of mice experimentally infected with Rn1691yn [A (10X); 
B (40X)]. In C the arrow indicates a necrotic hepatocyte (40X). Livers of 











proximal tubular epithelium was noted. The kidneys of saline inoculated 
control mice did not demonstrate any areas of inflammation [Figure 3.4C-D 
















Figure 3.4 Hematoxylin and eosin stained sections show granulomatous 
lesions in the kidneys of mice infected with high doses of Rn1691yn [A 
(10X); B (40X)]. Kidneys of saline inoculated control mice did not display any 
lesions [C (10X); D (40X)]. 
 
     Inflammatory or granulomatous lesions were not observed in other 
organs examined (heart, bladder, spleen, thymus, lung, and lymph nodes) 
from experimentally infected mice. Matching organs from saline inoculated 
control mice did not demonstrate lesions. 







     Of four rat bartonella strains evaluated in this experimental infection 
study, only one, Rn1691yn, demonstrated an ability to infect mice. This 
represents a cross-genera host switch for this bartonella strain, a somewhat 
uncommon observation in the context of bartonella infection studies in mice 
[145, 210, 226, 231]. Rn1691yn was originally isolated from R. norvegicus in 
Yunnan Province, China [136], and appears to be a strain of B. 
coopersplainensis, a species later isolated and genetically characterized from 
R. leucopus in Australia [22] (Figure 3.1). Compared to the other three 
strains evaluated strains similar to Rn1691yn have been reported from a 
greater number of rodent genera worldwide [BLAST nucleotide sequence 
query, NCBI; Rn1691yn gltA sequence; ≥96% maximum identity]. This 
suggests that the infection phenotype observed in the laboratory is 
representative of the natural broad host range of B. coopersplainensis strains 
observed during field studies.   
     Mice responded to experimental infection in a dose dependent manner in 
two ways. First, a greater number of mice became infected at high bacterial 
doses than lower. Second, a temporal response was noted in response to the 
doses inoculated. Mice exposed to higher doses usually became bacteremic 
soon after infection (within a few weeks), whereas mice inoculated at lower 
doses demonstrated greater variability in time to bacteremia onset. Three 
mice inoculated at lower bacterial doses did not develop bacteremia until 2—
4 months post-inoculation. The highest bacteremia level observed in infected 




levels and longer duration of bacteremia have been reported in natural hosts 
[112, 240] versus incidental hosts, and alterations in bacteremia kinetics 
may be a fitness trade-off for the bacteria when it infects a host to which it is 
not adapted. Lower bacteremia levels of shorter duration in incidentally 
infected rodent hosts also suggests that bacterial acquisition from these 
hosts by arthropod vectors may be compromised so the contribution of 
incidental host infections to natural transmission cycles of the bacteria may 
be negligible.  
     The failure of the other three rat bartonella strains to infect mice suggests 
those strains are host specific at the genus level. Bacterial host specificity 
appears quite common in rodent populations and has been observed in 
numerous field studies and in experimental infection studies using different 
Bartonella species in different host taxa (Chapter 1). By comparison 
Rn1691yn readily infected mice, a cross-genera host switch for this 
bacterium from its host of origin. Thus Rn1691yn seems inherently more 
capable of utilizing a mouse alternative host than the other three rat 
bartonella strains evaluated. This suggests that not all rat associated 
bartonellae have the same zoonotic potential and that human infection risk 
can vary according to which rodents and circulating strains are present in a 
particular location. The low, detected incidence of human cases of zoonotic 
bartonella infection, not including B. henselae infections, may be in part due 
to high levels of bacterial host specificity. Incidental human infections also 
likely require some measure of individual host susceptibility, as observed in 




experience temporal lags before illness manifests this could make it more 
difficult to pinpoint specific exposure events leading to their infections [165, 
171]. It should be noted that most mice that became bacteremic were 
inoculated with high doses of Rn1691yn (104—107 cfu), and the dose required 
to infect a susceptible human or natural reservoir host for B. 
coopersplainensis is unknown. 
     Temporal lags in manifestation of bacteremia following exposure of 
rodent hosts to bartonellae circulating in their communities may be common 
in nature. Though we know  little about which hematophagous arthropods 
may transmit bartonellae and what their transmission efficiency may be [47, 
148, 150], we can postulate that vector transmission would likely occur in 
the context of a low dose exposure. Thus variability in the time of exposure 
coupled with potential lags in host development of bacteremia could explain 
incongruities between indices of vector population abundance and infection 
prevalence, and host infection prevalence observed in  field studies [122, 
140]. It should also be noted that little is known about the rate or dynamics 
of bacterial acquisition by potential arthropod vectors, and differences among 
vectors in bacterial midgut colonization kinetics could also confound attempts 
to find correlations between vector and host infection prevalences. Finally, 
since most wild rodent populations are genetically heterogeneous (excluding 
founder effects), the variability observed in our outbred mice following 
infection can provide some insight into the variability of responses expected 




     No sentinel mice became infected and developed bacteremia including 
those co-housed with Rn1691yn bacteremic mice. Considering the high 
exposure rate of sentinel mice to infected cage mates this observation seems 
to rule out contact with cage mates or their feces or urine as a transmission 
mode, at least for this strain. However, this lack of transmission may be an 
experimental artifact. Since mice in our study had relatively low bacteremia 
levels of short duration compared to natural hosts this may have influenced 
the outcome of this assessment [112, 137, 240]. Still, more likely modes of 
bartonella transmission among rodents exist such as the bites of 
hematophagous arthropods [148, 150]. 
     Persistent bacteremias in infected rodent hosts are usually considered an 
indicator for adaptation of a bartonella strain to that host, and the paradigm 
for this type of co-adaptation is that the bacteria causes no deleterious effect 
to the host [109]. However, in our study bacteremic mice developed organ 
lesions following inoculation of high bacterial doses. Similar findings have 
been described in two other murine infection studies using bartonella human 
pathogens, although those mice did not develop bacteremias [210, 242]. 
Mice inoculated with B. henselae developed liver granulomas which resolved 
after 3 months, and no significant pathology was observed in other organs 
examined [210]. Liver lesions in those mice were not associated with 
hepatocellular necrosis unlike the present study [210]. Rn1691yn inoculated 
mice examined 14 weeks post-infection had multiple large granulomas in 
their livers and kidneys. Whether these lesions would have resolved given 




number of factors. The inoculation route differed between the studies and 
may have influenced the outcome [224, 235, 243]. Also, mice infected with 
Rn1691yn developed bacteremias unlike B. henselae inoculated mice. When 
we compare the current study with results reported for B. tamiae inoculated 
mice we find similar lesions in both the liver and kidneys [242]. However, 
Rn1691yn did not induce myocarditis or lymph node lesions as did B. tamiae, 
though it should be noted that aged mice were used in that study and young 
mice in the current study [242].  
     In summary we found that only one of four rat bartonella strains 
evaluated was able to infect mice [122, 140], indicating some level of host 
specificity for the other three strains. Our findings may contribute 
epidemiological and ecological insights into bartonella infection responses in 
natural and incidental hosts. The observation of pathology following 
bacteremia resolution in mice, coupled with the ability of Rn1691yn to cross-
genera host switch suggests a greater zoonotic potential for B. 
coopersplainensis strains than some other rat-associated bartonellae. The 
incidental host infection model we present here, weeks long bacteremia in a 
non-natural host with concomitant pathology seems to fit somewhere 
between two possible extremes of bartonella infection outcomes, i.e. no 
deleterious effect versus debilitating disease. Though much work remains to 
be done in terms of defining human exposure risk to bartonellae, our study 
provides some insight into the likelihood of bacterial host-switching by some 
rat bartonella strains, and establishes a basis for estimating the probability, 






EXPERIMENTAL INFECTION OF THREE LABORATORY MOUSE STOCKS 
WITH A SHREW ORIGIN BARTONELLA ELIZABETHAE STRAIN: HOST 
SPECIFICITY AND ZOONOTIC POTENTIAL  
 
INTRODUCTION 
     In peri-domestic and  peri-agricultural environments in many areas of the 
world, human contacts with rodents, lagomorphs and insectivores can pose 
heightened risk for acquiring zoonotic bartonellae infections [127, 165]. In 
Asia there are several species of rodents and an insectivore species, Suncus 
murinus, the Asian house shrew, that adapt easily to peridomestic 
environments and are frequently found infected with diverse bartonellae at 
high population prevalence [127, 129, 161]. These commensal small 
mammals often share a common ectoparasite fauna which may constitute a 
vector transmission risk to humans for bartonellae infections [130].  
     Rodents are often the focus of interest as reservoir hosts for bartonellae, 
but shrews have also been found to harbor both unique (shrew only) and rat-
associated bartonellae [127, 128, 138]. High sequence similarities between 
shrew isolates from geographically distinct areas in Asia support the 




bacteria, but they are also found infected with B. elizabethae-like strains 
[127, 128]. Infection of shrews with bartonellae closely related to rat strains 
likely represents spillover events. The proportion of sequence similarity 
between strains from different hosts in the same geographic location can 
indicate how recently the bacterial strains may have switched hosts. For 
example, a bartonella isolate from an Asian house shrew in Vietnam shares 
100% sequence identity with B. elizabethae by analysis of a portion of the 
citrate synthase gene (gltA). B. elizabethae was also isolated from two 
natural reservoir hosts, Rattus norvegicus and R. exulans, in that area as 
well. This finding points to an ongoing dynamic background of spillovers from 
rat populations into sympatric shrews. It also demonstrates the adaptability 
of a B. elizabethae strain in switching hosts, from rats to shrews, and 
suggests that this bacterium may have an inherent capacity to exploit new 
hosts.  
     Bartonella elizabethae and closely related strains have been implicated as 
agents of human disease [23, 165], and exposure to the bacteria seems high 
in some human populations, as revealed by serological surveys [196, 198, 
200]. Bartonella elizabethae-like strains are most commonly isolated from 
rats and rats unquestionably serve as zoonotic sources of human infection for 
many viral, bacterial, and parasitic diseases [143]. The likelihood that 
incidental hosts can be infected by shrew bartonella strains is unknown, but 
may be predicted based on the host-specificity of strains obtained from these 
animals [241]. Some bartonellae have been shown to infect a variety of 




     Shrews are mammals in the Order Soricomorpha, and infection of 
laboratory mice (Order Rodentia) with a shrew bartonella strain could 
demonstrate the host switching capacity of this bacterium. Therefore, we 
designed a study to evaluate the ability of our Asian house shrew B. 
elizabethae strain to switch from its host of origin to the laboratory mouse, 
Mus musculus. Three laboratory mouse stocks were inoculated with a range 
of bacterial doses, and susceptibility to infection and bacteremia kinetics of 
infected mice were observed. In this study we used mice with different 
genetic backgrounds, thus allowing for a broad range of observations and 
interpretation of response to infection [244]. Recognizing the importance of 
individual host immune status in susceptibility to infection, we chose inbred 
BALB/c mice, which tend toward a TH2 type immune response, and inbred 
C57BL/6 mice, which display a relatively robust TH1 response for the study 
[244]. We also included genetically heterogeneous, outbred Swiss Webster 
mice in our design to assess possible variability in individual host 
susceptibility, with respect to the other two mouse stocks. 
MATERIALS AND METHODS 
Mice and bacteria 
     Four to 6 week old Swiss Webster (SW) female mice were obtained from 
an outbred closed colony at DVBD, Fort Collins, Colorado, USA. Age matched 
BALB/c and C57BL/6 female mice were ordered from Jackson Laboratories 
(Sacramento, California, USA). Mice were group caged according to stock 
identity and bacterial dose for the study duration. All work on the mice was 




#07-004), in accordance with USPHS standards for the humane care of 
laboratory animals.   
     Passage history and other information about the B. elizabethae strain 
used in this study is detailed in Table 4.1 and does not include growth of 
bacteria for this study. Bacterial stock for mouse inoculation was prepared as 
described in Chapter 2. Bacterial stock concentration was determined as 
described previously (Chapter 2).  
Experimental design 
     Groups of 36 mice of each mouse stock were used in the study for a total 
of 118 experimental mice. Six mice were inoculated at each dose. Mice were 
inoculated only once, subcutaneously in the in the dorsal midline between the 
scapulae with bacterial doses ranging from 101 to 106 cfu, diluted in saline to 
350µl.  Beginning 1 week post-inoculation through week 13 blood was 
collected weekly from mice as described in Chapter 3. Volumes of 75 -125µl 
of blood were collected from each mouse weekly. Samples were stored at -
80°C until tested for bacteremia. 
Testing for bacteremia 
     Frozen whole blood samples were thawed, and diluted (50µl blood : 150µl 
brain heart infusion with 20µg/ml Fungizone™ added). Heart infusion agar 
plates enriched with 5% rabbit blood were inoculated with 100ul of the 
diluted samples, and placed in a CO2 incubator at 35˚C for 10 – 21 days to 
permit bacterial growth. Bacteremic blood samples were subsequently diluted 





Table 4.1 The low passage Bartonella elizabethae strain used in this study 
was originally isolated from the Asian house shrew, Suncus murinus. 
 
Asian house shrew  
Bartonella elizabethae 
strain  Sm6145vi 
Place of origin Dong Nai Province, Vietnam (2003) 
Primary isolation 
 
Whole blood inoculated onto BHI1 




(n = number of passages) 
BHI supplemented with 5% rabbit blood, 
n = 3; 
BALB/c in vivo2, n = 1;  
BHI supplemented with 5% rabbit blood, 
n = 2 
Nucleotide sequence  
[GenBank accession 
number] gltA [JF523414 ] 
 
confirmed as bartonella by colony morphology and microscopic appearance 
as small, Gram negative bacilli following Gram staining.  
RESULTS 
Infection of Swiss Webster mice 
     Following inoculation with B. elizabethae Sm6145vi, 2 of 36 SW mice 
became infected and developed bacteremia, 1 of 6 at the 106 cfu dose and 1 
of 6 at the 105 cfu dose (Figure 4.1). Bacteremia lasted 7 weeks in the 106 
cfu dose SW mouse, and 6 weeks in the 105 cfu dose mouse. Onset of 
bacteremia occurred 3 weeks post-inoculation for both mice, but level at 
onset for the 106 cfu dose mouse was 2.1 X 104 cfu/ml blood, whereas level 
at onset for the 105 cfu dose mouse was 60 cfu/ml blood. The 106 cfu dose 




(3.1 X 104 cfu/ml blood). Swiss Webster mice inoculated with 104 cfu or less 
of Sm6145vi failed to develop bacteremias. 
 
           Figure 4.1. Bacteremia kinetics of Swiss Webster mice infected with  
           B. elizabethae Sm6145vi. 
 
Infection of BALB/c mice 
     One of six BALB/c mice became infected following inoculation with a 106 
cfu dose of the bacteria. The duration of bacteremia for this mouse was 7 
weeks, with onset at week 1 post-inoculation (Figure 4.2). The level of 
bacteremia at onset was 1.5 X 104 cfu/ml blood, which was also the highest 
level of bacteremia observed in this mouse over the course of infection. This 
mouse had the earliest onset of bacteremia (week 1) of any bacteremic 
mouse in the study. BALB/c mice inoculated with 105 cfu or less of B. 





             Figure 4.2 Bacteremia kinetics of a BALB/c mouse infected with  
             B. elizabethae Sm6145vi. 
 
Infection of C57BL/6 mice 
     Two of six C57BL/6 mice became infected following inoculation of 106 cfu 
of Sm6145vi and developed bacteremias lasting 7 and 8 weeks in length 
(Figure 4.3). These two mice developed the quantitatively lowest levels of 
bacteremia observed in the study. Onset of bacteremia was observed at 
weeks 2 and 3 for the mice, with levels at onset of 615 and 35 cfu/ml blood, 
respectively. Bacteremia peaks observed for the mice were 2.9 X 103 and 
755 cfu/ml blood, again respectively. C57BL/6 mice inoculated with 104 cfu 
or less of B. elizabethae Sm6145vi failed to develop bacteremias. Bacteremic 
mice of all three stocks in the study showed fluctuations in their levels of 





          Figure 4.3 Bacteremia kinetics of C57BL/6 mice infected with  
          B. elizabethae Sm6145vi. 
 
next. Finally, no control mice tested positive for bartonella bacteria at any 
time during the study period.   
DISCUSSION 
     In this study an Asian house shrew B. elizabethae strain (Sm6145vi) 
infected laboratory mice, a demonstration of cross-order host switching by 
the bacteria (from Order Soricomorpha to Order Rodentia). This is to some 
extent an unusual finding as bartonella bacteria generally only infect and 
produce bacteremias in hosts taxonomically close to their natural reservoir 
hosts [112, 124, 145]. The ability of this strain to host switch across 
mammalian orders defines a characteristic of the bacteria that can make it 




B. elizabethae strain was isolated from a shrew its close phylogenetic 
relatedness to rat isolates of B. elizabethae in the same location means it is 
likely a spillover from rats to sympatric shrews in Vietnam. Therefore, unlike 
some other bartonellae this strain seems to have an inherent capacity to 
infect diverse hosts [145]. It should be noted however, that bacteremias 
occurred only in those mice inoculated with high doses of B. elizabethae 
Sm6145vi (105 and 106 cfu), and it remains uncertain how many bartonella 
bacteria are required to establish host infection under natural conditions.   
     Bartonella elizabethae has been reported as the causative agent of 
several cases of human illness [23, 165]. Still, the zoonotic potential of this 
bacterium is not well understood. Since B. elizabethae and strains 
phylogenetically close to it have been found in numerous commensal small 
mammal populations in Asia [127, 245], an understanding of the risk to 
humans for acquiring infections from these hosts is desirable. Given that the 
level of host specificity of an infectious agent is generally considered a 
predictor for the likelihood that the agent can switch hosts, and potentially 
cause illness in those hosts, our findings help define the zoonotic potential of 
this bacteria [241].   
     Previously B. elizabethae isolated from a human endocarditis patient was 
evaluated for its ability to infect several different rodent species, among 
them R. norvegicus, a natural reservoir host for the bacteria [23, 145]. In 
that study, the bacteria failed to infect Wistar rats (R. norvegicus), cotton 
rats (Sigmodon hispidus), BALB/c (M. musculus), and white-footed deer mice 




bacteria [145]. It remains unknown whether the bacteria had undergone 
adaptation to the human host resulting in a high level of host specificity, or 
whether the isolate’s passage history might have influenced the outcome 
[246]. An additional unanswered question was whether related isolates from 
natural reservoirs would also display a narrow host range, or limited host 
specificity phenotype.   
     In contrast to those findings we observed susceptibility of three stocks of 
M. musculus (SW, BALB/c, and C57BL/6) to infection with B. elizabethae 
Sm6145vi at doses of 105–106 bacteria. Mice developed  bacteremia levels 
potentially high enough to infect ectoparasites, such as fleas, feeding on a 
host during the course of bacteremia [147]. The bacteremia levels observed 
in our incidental host mouse model may be sufficient to promote some 
secondary infections of susceptible hosts, especially if high enough levels of 
bacterial exposure exist, in terms of transmissible contacts, between animals.  
     Bacteremia of several months duration or more are commonly observed 
in reservoir hosts infected with their co-adapted bartonellae [109, 111, 112]. 
The bacteremia duration of mice in our study is shorter than that observed 
during such natural host infections, but is consistent with bacteremia kinetics 
of laboratory mice experimentally infected with non-homologous host source 
bartonellae [85, 235]. Truncations in bacteremia duration are likely due to 
the bacteria not being optimally adapted to laboratory mice, and are 
probably characteristic of non-natural host infections [85, 235].  
     Similar, small proportions of mice of each stock used in this study were 




elizabethae strain Sm6145vi. The differing genetic backgrounds among the 
three stocks did not appear to affect susceptibility of mice to infection, at 
least not with the dose range assayed. It is possible that inoculation of larger 
group sizes would reveal more apparent differences between stocks. We did 
not attempt to assess for differential response to infection for the three 
mouse stocks at different exposure doses, as the number of bacteremic mice 
in each dose group was low. It would be difficult to assign a biologically 
significant interpretation to such slight differences in infection rates, and 
level and duration of bacteremia, without knowing that the observed 
differences are relevant to the transmission dynamics of the bacteria. 
Bacteremia duration in infected hosts almost undoubtedly affects the 
transmission likelihood of the bacteria. Simply put, long bacteremias increase 
the size of the temporal window for potentially transmissible contacts to 
occur between infected hosts and susceptibles, or for arthropod vectors to 
acquire the agent [241]. Likewise, high bacteremia levels can influence the 
probability that contacts with infected hosts result in bacterial transmission, 
or arthropod vectors become infected following ingestion of infectious blood 
[241]. However, to reasonably extrapolate our laboratory based findings to 
the natural transmission cycle of B. elizabethae additional studies need to be 
done to define the transmission dynamics of the bacteria in its normal hosts. 
     Further evaluations of B. elizabethae Sm6145vi could yield more 
information about this bacterium’s host specificity, adaptive capacity, and 
zoonotic potential. Additional in vivo passage(s) of the bacteria in laboratory 




differences in the ability of a mouse adapted clone to infect the different 
mouse stocks. Such an experiment could also provide insight into B. 
elizabethae’s rate of adaptation to a new host. Alternatively, experimental 
infection studies could be done to evaluate the ability of this bacterium to 
infect R. norvegicus and R. rattus, natural reservoir hosts of B. elizabethae 
[99, 143], to determine if adaptation to other hosts has altered its capacity 
to infect its natural hosts [145]. Knowledge gained about the zoonotic 
potential of B. elizabethae strains can aid us in implementing measures to 
reduce human infection risk in areas of the world where these strains 






EXPERIMENTAL INFECTION OF AGED LABORATORY MICE WITH A 
MOUSE ORIGIN BARTONELLA STRAIN AND THREE HUMAN ORIGIN 
BARTONELLA TAMIAE STRAINS: TAXONOMIC DISTANCE AS A 
PREDICTOR OF INFECTION OUTCOME  
 
INTRODUCTION 
     In a world where almost every living creature seems to be infected with 
bartonella bacteria how do we determine which of the strains circulating in 
wildlife have zoonotic potential? Are all bartonella strains equally able to 
infect animals other than their natural hosts, or do some strains have a 
greater ability to do so? From an epidemiological perspective are all hosts 
created equal, or do some alternate hosts exhibit characteristics that make it 
more likely that they can become infected? Knowing the answers to these 
questions and other related questions is critical to putting together a picture 
of how, when, and where zoonotic bartonellae may emerge to infect 
incidental hosts [247-249]. Equally critical is an understanding of host 
responses to bacterial exposures [250].  
     It appears that bartonella infection outcomes in immunocompetent hosts 




origin and the incidental host it infects. The closer the taxonomic distance 
between the host of origin and the incidental host, the more likely it will be 
to become infected and become bacteremic. Conversely, it appears that the 
greater the taxonomic distance between the host of origin and the incidental 
host, the more likely the incidental host is to either clear the bacteria or to 
develop pathology subsequent to bacterial exposure. Still, strict partitioning 
of potential host responses according to only a single criterion, host of origin 
for a bartonella strain, is unlikely to be warranted. In Chapter 3 laboratory 
mice exposed to a rat bartonella strain (Rn1691yn) developed kidney and 
liver pathology. Not only was a dose response observed for those groups but 
within a group individual mice displayed differential responses. The 
observation that only 1 of 5 mice inoculated at the 106 cfu dose of Rn1691yn 
developed kidney lesions versus 5/6 at the 107 cfu dose suggests a dose 
effect for bacterial infection and pathological outcome. Along with dose 
effect, individual host susceptibility also appears to play a role in infection 
outcome.   
     When animals are exposed to bartonella strains originating from hosts of 
different species or genera, they may or may not develop bacteremias 
(Chapters 2-4). It often seems that the duration and magnitude of 
bacteremia in non-natural host animals is truncated and of a lower level 
relative to bacteremia kinetics reported for the natural host [85, 227, 235]. 
This is probably because that bacterium is not adapted to that alternate host. 
We do not presently know how many humans are exposed to bartonella 




from infection. Serological surveys conducted to assess exposure of high risk 
human populations to rodent-associated bartonella strains consistently 
demonstrate exposures to these bacteria [183, 193-197, 199-203, 251]. 
When humans become infected with zoonotic bartonellae the outcome is 
unknown except in cases where clinical disease develops, medical care is 
sought by patients and a diagnosis is made. The mouse infection studies 
described in Chapters 2—4 suggest that dose, bacterial strain, and individual 
host susceptibility can all play a role in infection outcome.  
     The role of individual host susceptibility to infection must be accounted 
for when considering all potential outcomes following bacterial exposure . 
Some mice did not become bacteremic following exposures to Mus species 
bartonella strains (Chapter 2), whereas a few mice became bacteremic 
following exposure to a shrew source bartonella strain (Chapter 4). Whether 
taxonomic distance is a better predictor of outcome than individual host 
susceptibility is arguable.    
     The use of outbred mouse strains in all of the studies reported in this 
dissertation has revealed variation in susceptibility and response to exposure 
likely due to the genetic heterogeneity of the mice. Though few studies have 
been conducted documenting heterogeneity of outbred mice strains, several 
report measures of allelic diversity in outbred mouse strains commensurate 
with the diversity in wild type M. musculus [252-254]. Thus, the variability in 
response observed can likely be considered representative of a natural 
mouse (rodent) population. There is no clear evidence that either inbred or 




immune systems can better reproduce disease states associated with 
bartonella infections in humans (Chapter 1, Table 1.3). However, the 
majority of human patients identified as having zoonotically acquired 
bartonella infections or experiencing adverse outcomes associated with 
bartonella infections are approaching middle age (Chapter 1, Table 1.2). This 
suggests that age related changes in immune function may affect the 
outcome of some bartonella infections by affecting individual host 
susceptibility to infection [250]. Adding an age variable to an experimental 
infection study that evaluates the ‘taxonomic distance as predictor of 
infection outcome’ can potentially increase the sensitivity of the system to 
separate outcomes related to individual host susceptibility from outcomes 
that are inevitable due to the intrinsic characteristics of the bartonella strains 
used.  
     We previously assessed whether exposure of mouse stocks with well 
documented differences in their immune response would respond 
differentially to exposure to a B. elizabethae strain and no apparent 
differences were observed (Chapter 4). Immunological senescence 
represents changes in immune response related to aging, and is not 
commensurate with specific defects in immune function or response such as 
those observed in genetically modified laboratory mouse strains 
[www.informatics.jax.org] [255]. Immune senescence may produce  
impairments or attenuation of immune response but is not typically 
characterized by a complete lack of function of any component of the system 




     To explore whether age could influence infection outcome we 
experimentally infected groups of aged mice with either a mouse bartonella 
strain or with strains of a human origin Bartonella species. The strains 
evaluated represent opposite ends of the spectrum for host of origin: mouse 
versus human. A previous study showed that outbred mice were susceptible 
to infection with the mouse bartonella strain and would develop bacteremias 
(Chapter 2). The natural reservoir host(s) of B. tamiae are unknown but 
these strains were isolated from humans so for our purposes the B. tamiae 
strains used in this experiment are pathogens of human origin.      
     If we accept taxonomic distance as a predictor for infection outcome then 
strains of B.tamiae should not produce bacteremias, even in aged mice. If 
experimental results deviate from the expected outcome it would suggest 
that individual host susceptibility may be a more powerful predictor of 
bartonella infection outcome than previously considered. In that scenario, 
human risk for acquiring bartonella infections should be evaluated in the 
context of potential host susceptibility to infection along with information 
about which circulating bartonella strains human populations may be 
exposed to through animal or arthropod contacts.    
MATERIALS AND METHODS 
Mice and bacteria 
    Four groups of six CD1 female mice aged 10 months were each 
subcutaneously inoculated with 106 cfu of a mouse bartonella strain (MA) or 
with B. tamiae strains Th239, Th307, Th339 (n = 24 mice total) as described 




kept separate from one another for the duration of the study.  The mouse 
bartonella strain used in this experiment is the strain designated MA in 
Chapter 2. The B. tamiae strains used in this experiment, Th239, Th307, and 
Th339, were originally isolated from infected human patients in Thailand 
(Table 1.2, Chapter 1) and their passage history is detailed here in Table 5.1  
 
Table 5.1 The Bartonella tamiae isolates used in the study have different in 




Primary isolation from  
human blood samples 
[30] 
Subsequent passage history  
(n = number of passages) 
Th239 
Blood clot from Thai patient 
inoculated onto Vero E6 cells 
HIA supplemented with 5% 
rabbit blood, n = 6 
Th307 
Blood clot from Thai patient 
inoculated into BAPGM  
HIA supplemented with 5% 
rabbit blood, n = 2 
Th339 
Blood clot from Thai patient 
inoculated onto Vero E6 cells 
BAPGM, n = 1; HIA 
supplemented with 5% rabbit 
blood, n = 2 
 
HIA = Heart Infusion Agar plates 
BAPGM = Bartonella/alpha-Proteobacteria growth medium [9] 
 
Blood collections and bacteremia testing 
    Blood was collected from each mouse in the study weekly for 6 weeks as 
previously described (Chapter 2). Blood was frozen at -20°C until 
microbiological testing. To test for bacteremia blood was thawed and 50µl 
was added to 50µl of brain heart infusion diluent with 8% amphotericin B. 
Samples were inoculated onto plates and incubated as described in Chapter 




numerous to count were diluted 1:1,000 and 1:10,000 to allow for 
enumeration of bacteria. Colonies were counted 7—10 days after growth first 
appeared. 
RESULTS 
     All six mice inoculated with the mouse bartonella strain (MA) became 
bacteremic in the first week post-inoculation (Figure 5.1). Bacteremias were 
maintained over the 6 week study duration and reached levels >106 cfu/ml in 
2 of the 6 mice (Figure 5.1). No mouse inoculated with a B. tamiae strain 
became bacteremic at our level of detection during the course of the study.  
 
Figure 5.1 Bacteremia kinetics for aged SW female mice experimentally 







     In this study aged female CD1 mice infected with a Mus species 
bartonella strain developed bacteremias following inoculation commensurate 
with the response observed in younger (8 weeks old) female CD1 mice 
(Chapter 2). This simple comparison between outcomes across different age 
groups suggests that, at least for strain MA, age alone might not be a 
determinant of successful infection (i.e. bacteremia manifestation). Mice 
inoculated with B. tamiae strains, however, did not become bacteremic. In 
this experimental system taxonomic distance was a good predictor of 
infection outcome. Since all six mice infected with the mouse bartonella 
strain became bacteremic it does not appear that mouse age affected 
susceptibility to infection. However, unlike the young mice that were 
inoculated with low doses (10, 100, and 1000 cfu), older mice were 
inoculated with 106 bacteria/mouse and might have displayed a different 
response to lower dose inocula.  
     Mice in this study were only observed for 6 weeks so their duration of 
bacteremia is unknown. Bacteremia duration in younger mice was months 
long and based on similarities in the initial pattern of response it is likely that 
the older mice would have maintained bacteremias for extended periods as 
well. Aged mice did not attain bacteremias at levels of 107 cfu/ml blood as did 
younger mice. This might be due to age-related differences in physiology or 
immune response in older mice as compared to younger [255-257]. 
However, no data were collected to evaluate antibody response to infection in 




explanation is that the dynamics of response were affected by the bacterial 
dose. The research reported in this dissertation suggests that bacterial dose 
can influence the magnitude and duration of bacteremias (Chapters 2—4). 
     Mice inoculated with B. tamiae strains failed to develop bacteremias at 
our level of detection, not surprising as these strains were obtained from ill 
human patients. Though these strains have presumably already successfully 
accomplished a host switch by infecting humans this does not seem to have 
made them promiscuous for infection of another host. Adaptive changes 
likely occurred in the bacterial population during the course of infection. For a 
bacterium an infection would represent many generations upon which the 
selective pressures imposed by a new host could act.  
     Bartonella strains obtained from humans have been consistently unable 
to produce bacteremias in laboratory mice. This has been demonstrated for 
isolates of B. bacilliformis, B. quintana, B. henselae and B. elizabethae [145, 
209, 210, 231]. Though B. tamiae inoculated mice did not manifest 
bacteremias, it is possible they might develop pathology following exposure 
as do mice infected with B. henselae. Future investigations into whether aged 
mice develop disease following exposure may be warranted, especially since 
older humans seem more susceptible to pathological outcomes from 






HUMAN ISOLATES OF BARTONELLA TAMIAE INDUCE PATHOLOGY IN 
EXPERIMENTALLY INOCULATED, AGED, IMMUNOCOMPETENT  
SWISS WEBSTER MICE 
 
INTRODUCTION 
     Numerous bartonella strains are isolated from rodents and other wildlife 
each year (Bartonella Laboratory, CDC, Fort Collins). Strains are also 
infrequently cultured from clinical samples obtained from bartonella infected 
human patients (Chapter 1, Table 1.2). During isolation information is 
collected about strain growth characteristics in eukaryotic cell culture and on 
microbiological media. Isolates are genetically characterized and nucleic acid 
sequences are deposited in GenBank (NCBI) to allow public access to the 
information. However, other biological information about the strains is often 
lacking such as whether they could infect laboratory mice. This could be an 
indicator of their host specificity and by implication their zoonotic potential. 
When bartonella strains are inoculated into mice observations can be made 
about the outcome of these exposures. Screening strains in this way can 
provide clues about whether a suspect isolate might be the actual cause of a 




     Bartonella tamiae was originally isolated from hospitalized human 
patients in Thailand. That fact coupled with the absence of detection of other 
pathogens in the patients, as well as clinical syndromes compatible with 
bartonellosis led to the presumption that the bacterium was the cause of the 
patients’ illnesses. However, an association with illness is not the same as 
causality. Infectious disease research is ruled by the fundamental concepts 
embodied in Koch’s postulates. Since it is not ethically feasible to inoculate 
humans to see whether illness and disease could be reproduced, and since 
non-human primates are difficult to work with as well as extremely expensive 
to use as animal models, laboratory mice are often assayed in their stead.  
     If mice exposed to a suspected human pathogen become ill and display 
disease similar to that observed in ill people, and if the pathogen can be 
recovered from the mice then a major step toward satisfying the question of 
causality could be realized. For us, this would mean that the suspected role 
of B. tamiae as the causative agent of the Thai patients’ illnesses could 
potentially be strengthened or confirmed. 
     In a previous study, aged mice inoculated with B. tamiae failed to develop 
bacteremias (Chapter 5). Though it seemed unlikely that Koch’s postulates 
could be satisfied due to our inability to recover viable bacteria from exposed 
mice, there was still a possibility that the disease states observed in B. 
tamiae infected humans could be reproduced (Chapter 1, Table 1.2) [258]. 
No histological analysis of tissues had been done to investigate whether the 
bacterium might have induced pathology in the mice. We hypothesized that if 




might observe pathology in mice experimentally infected with the bacteria. 
Therefore we inoculated groups of aged mice with the three available strains 
of B. tamiae. If lesions were observed in their organs consistent with disease 
symptomatology observed in human patients from whom the bacteria were 
isolated then our observations would establish a murine model for B. tamiae 
induced disease, and serve to implicate B. tamiae as a causative agent of 
human illness in Thailand. 
MATERIALS AND METHODS 
Mice and bacteria 
     Specific pathogen free, outbred Swiss Webster female mice aged 15-18 
months were used for this study. Mice were obtained from a colony of Swiss 
Webster mice maintained at DVBD. Work with the mice was approved by, 
and conducted under the supervision of the DVBD IACUC [protocol # 07-012] 
in compliance with the standards for humane care of laboratory animals 
published by the USPHS.  
     Bacteria for the mouse inoculations were grown on heart infusion agar 
plates supplemented with 10% rabbit blood, in a 5% CO2 incubator at 35˚C. 
Stocks were prepared for mouse inoculations as described previously 
(Chapter 2). The in vitro bacterial passage history for each of the three B. 
tamiae isolates is detailed in Table 5.1 in Chapter 5 and does not include 
preparation of the stocks described above. 
Experimental design and inoculation of mice 
     All experimental mice were inoculated subcutaneously along the dorsal 




of one of three B. tamiae strains (Th239, Th307, or Th339) [258]. Three 
groups of four mice were chosen from the available pool of age matched 
female mice for this experiment. Each group was randomly assigned to be 
inoculated with one of the three available B. tamiae strains, such that four 
mice were inoculated for each of the three strains [n = 12 experimental 
mice]. Two age-matched female mice were subcutaneously inoculated with 
saline to serve as controls.   
     Mice were group housed by strain for the duration of the study and 
control mice were held separately from experimental mice. One mouse in 
each group was sacrificed at 3, 4, 5, and 6 weeks post-inoculation (n = 1 
mouse per time point for each isolate). All of the following tissues were 
sampled from each mouse to include both experimental and control mice: 
blood, spleen, liver, lymph node(s), and kidney. Lymph nodes collected 
included axillary, brachial, inguinal, popliteal, and cervical nodes, generally in 
pairs. Lymph nodes were pooled for testing by PCR. Hearts were collected 
from mice during weeks 4 and 5 post-inoculation (n = 6 hearts total; 4 
experimental and 2 control mice). Control mice were sacrificed at 4 and 5 
weeks post-inoculation. 
Gross observations 
     Mice were examined by visual inspection and manual palpation in the 
weeks following inoculation. Lymph node enlargement was noted, as were 
the location and number of skin lesions (Figure 6.1). Enlargement of axillary 
and inguinal lymph nodes was monitored by palpation, with reference to 




Polymerase chain reaction (PCR) detection of bartonella DNA 
     Genomic DNA was extracted from tissues and blood sampled from Swiss 
Webster mice sacrificed at 3, 4, 5, and 6 weeks after inoculation with three 
B.tamiae strains, and from saline inoculated control mice. A 200ul sample of 
blood and 10—30mg each of various tissues (lymph nodes, liver, spleen, 
kidney, and subcutaneous masses) from each mouse was subjected to DNA 
extraction using the manufacturer’s blood or tissue protocol as outlined in the 
QIAamp DNA Mini kit handbook (Qiagen, Valencia, CA). Extracted DNA was 
stored at -20o C until tested.  
     Bartonella tamiae DNA in samples was detected by PCR using bartonella 
specific primers targeting the gltA (citrate synthase gene) [259], and 16S-
23S rRNA intergenic transcribed spacer (ITS) region [260] (Table 6.1). 
Polymerase chain reaction  was performed in 50 μl reaction volumes 
containing extracted template DNA, 10μl of 5X Green GoTaq reaction buffer, 
200μM of each dNTP, 0.5μM of each forward and reverse primer and 1.25 U 
of Taq DNA polymerase (Promega, Madison, WI), in an Eppendorf 
Mastercycler (Eppendorf, Westbury, NY). The conditions for the gltA reactions 
were 2 min at 95˚C, 35 cycles at 95˚C for 30 s, 50˚C for 45 s, 72˚C for 30 s, 
and a 7 min extension at 72˚C. The ITS PCR conditions were 2 min at 95˚C 
followed by 40 cycles of 95˚C for 30 s, 66˚C for 1 min, 72˚C for 1 min and a 7 
min extension at 72˚C. PCR products were visualized on a 1.5 % agarose gel, 
and amplicons matching the target length were sequenced on a 3130 Genetic 





Table 6.1 Bartonella tamiae DNA in samples was detected by PCR assay 
using Bartonella specific primers. 
 
Primer 
name Primer sequence 5’--3’ 
Amplicon 
size (bp) Reference 














Tissue preparation for histopathological analysis 
     Tissue samples were fixed in 10% neutral buffered formalin (Fisher 
Scientific, Kalamazoo, MI), subjected to standard processing, and embedded 
in paraffin. Sections of 5μm were then prepared and stained with 
hematoxylin and eosin for evaluation by light microscopy (Colorado Histo-
Prep, Fort Collins, Colorado, USA), and with Warthin-Starry stain (Atlanta, 
CDC). Age-matched, saline inoculated control mouse tissues were treated in 
similar fashion, and all sections were read without prior knowledge of the 
experimental groups. 
RESULTS  
Examinations of inoculated mice—gross observations 
     Within the first week following inoculation all mice exhibited thickened, 
tough skin at the inoculation site in the scruff of the neck. This resolved in 
surviving mice by week 4. The scruff skin of saline inoculated control mice 
remained thin and supple throughout the course of the study. All mice 




thorax from 2 weeks post-inoculation (Figure 6.1A, B), and some of these 
were still present at the conclusion of the study (6 weeks). Inguinal lymph 
node 
enlargement was easily detectable by palpation in mice during this same 
 
 
   











Figure 6.1 Enlarged lymph node, lateral thorax, with overlying superficial 
dermal lesion in a mouse inoculated with Th307 3 weeks post-inoculation (A, 
B). Axillary and inguinal lymph nodes of mice inoculated with three strains of 
B. tamiae were enlarged and were evident during physical exams (C, D).  
 
time period, and in some mice axillary lymph nodes felt enlarged as well 
(Figure 6.1C, D). Between weeks 2 and 3 mice inoculated with isolates Th307 







lymph nodes (Figure 6.1A). Mice inoculated with Th239 did not develop skin 
ulcerations above enlarged lymph nodes. The lymph nodes did not appear 
painful upon palpation at any time during the course of the study, i.e. mice 
did not display aversion to handling or palpation of lymph nodes at any time. 
PCR detection of bartonella DNA 
     Sequencing of PCR positive samples confirmed the presence of B. tamiae 
DNA in two types of mouse tissues (Table 6.2). Bartonella tamiae DNA was 
detected 3 weeks post-inoculation in a thoracic lymph node and the liver of a 
mouse inoculated with Th339. DNA was also detected in two different lymph 
nodes from another mouse inoculated with Th339, 5 weeks post-inoculation. 
One mouse inoculated with Th307 was also found to have a B. tamiae DNA 
positive thoracic lymph node at week 3. No blood or tissue samples collected 
from mice inoculated with Th239 contained detectable B. tamiae DNA. 
Samples collected from the two saline inoculated control mice were not found  
 
Table 6.2 Bartonella tamiae DNA was detected in tissues of inoculated mice 




inoculation B. tamiae isolates Tissue sample gltA ITS 
3 Th339a Thoracic lymph node + + 
3 Th339a Liver - + 
3 Th307 Thoracic lymph node + + 
5 Th339b Thoracic lymph node - + 
5 Th339b 
Lymph node 
(axillary or inguinal) 
+ + 
 




b the same mouse 
SQ = subcutaneous 
to contain B. tamiae DNA by PCR analysis. Nucleotide sequence analysis 
indicated that the detected DNA was identical to the inoculated strains. 
Histopathological observations 
     No bacteria were observed in tissue sections stained with Warthin-Starry 
stain. Observations below are described from hematoxylin and eosin stained 
tissue sections. Differences in pathogenicity among B. tamiae isolates were 
noted (Table 6.3). Th307 appeared less pathogenic than Th239 or Th339 
when inoculated into mice, as only a deep dermatitis was seen at week 3 and 
a multifocal granulomatous nephritis was noted at weeks 5 and 6 after 
inoculation. This contrasts with Th239 and Th339 where granulomatous 
lesions were noted within the heart, kidney, liver and spleen of inoculated 
mice (Table 6.3). Lesions in the dermis occurred early after inoculation with 
Th307 and Th339 (3 weeks), while lesions of internal organs induced by all 
three strains were noted at week 4 and persisted through week 6 post-
inoculation (the duration of the study). At week 5 a diffuse myocarditis was 
noted in the hearts of mice inoculated with Th239 and Th339. Inflammation 
consisted primarily of mononuclear cells (lymphocytes and plasma cells) 
admixed with neutrophils occurring between myocytes (Figure 6.2-A). As 
noted in Figure 6.2-B, pyknotic nuclei and necrosis of adjacent myocardial 
muscle  
cells was seen (Figure 6.2-B, arrow). Also, granulomas were seen within both 





Table 6.3. Histopathological observations in aged, immunocompetent mice 
inoculated with three different Bartonella tamiae strains. [NAF = No 
Abnormal Finding] 
 
Bartonella tamiae isolates 
Week post-




not oriented Necrotizing dermatitis 
Spleen NAF NAF NAF 
Liver NAF NAF NAF 
4 
Skin NAF NAF Necrotizing dermatitis 






response in sinusoids 
Kidney 
Granulomatous 
nephritis NAF NAF 
5 
Spleen NAF  
Hemosiderosis in the 
cortex  





Granulomas in the 




lymphadenitis NAF NAF 
Heart 
Myocarditis, 
granulomas right & 
left atria, infiltrates No sample 
Myocarditis, 
granulomas right & 
left atria, infiltrates 
6 
Skin No sample Deep dermatitis No sample 
Spleen 
Pyogranulomatous 
nodules in the red 
and white pulp NAF NAF 
Liver 
Hepatitis, granulomas 
















     In the liver, multifocal pyogranulomatous infiltrates were noted adjacent 
to central veins (Figure 6.3-A) in association with hepatocellular necrosis 
(Figure 6.3-B, arrow).  In the kidneys a perivascular granulomatous nephritis 
with associated degeneration and necrosis of glomeruli was noted in both 
kidneys (Figure 6.4-A, black arrows). These granulomas appeared to be 
associated with degeneration of proximal tubules (Figure 6.4-A, white 






Figure 6.2 Photomicrographs of hematoxylin and eosin stained heart sections 
of mice sampled during the study. Mononuclear cell infiltration of the 
ventricle (A, 10x; B, 40x) and atrium (C, 10x) of a Swiss Webster mouse 5 




myocyte with a pyknotic nucleus. (D) Ventricle of a Swiss Webster mouse 
inoculated with saline (10x). 
Lesions within internal organs appeared to be perivascular, and, as noted in 
Figure 4-B, a necrotizing vasculitis occurred in prominent arteries of the 
cortex of the lymph nodes draining associated skin lesions. In the spleen a 
necrotizing splenitis was seen with a mixed inflammatory response occurring 
within both the red and white pulp (not shown). In the case of a mouse 
inoculated with Th339 a diffuse and prominent hemosiderosis was also seen 





Figure 6.3 Photomicrographs of hematoxylin and eosin stained liver sections 
from mice sampled during the study. Granulomatous cell infiltration in liver 
tissue (A, 10x; B, 40x) of a Swiss Webster mouse inoculated with B. tamiae 
Th239. The black arrow indicates a necrotic hepatocyte. (C) Section of liver 






Figure 6.4 Photomicrographs of hematoxylin and eosin stained kidney and 
lymph node sections from mice sampled during the study.  
Granulomatous cell infiltration in the kidney (A, 10x) of a Swiss Webster 
mouse inoculated with B. tamiae Th239. Black arrows indicate degenerative 
glomeruli; the white arrow indicates a degenerating proximal tubule. (B) 
Necrotizing vasculitis in an axillary lymph node recovered from a Swiss 
Webster mouse 6 weeks after inoculation with B. tamiae Th339 (40x).   
     In the skin, caudal and lateral to the B. tamiae inoculation site, a 
necrotizing, ulcerative dermatitis developed dorsal to the subcutaneous 
masses early (3 weeks after inoculation of the mice with Th339, Table 6.3). 
The dermatitis persisted throughout the six week study period in some mice. 
Grossly, the lesions induced by Th339 appeared as ulcerative nodules, while 
microscopically, a severe, mixed inflammatory response was noted within the 
deeper layers of the dermis and subcutaneous tissues with associated 
necrosis of adjacent structures, such as hair follicles and sebaceous glands. 
Inflammatory infiltrates appeared similar to what was noted in the heart, 




cells, predominantly plasma cells and mature lymphocytes. None of the 
above described lesions were seen in saline-inoculated control mice. 
DISCUSSION 
     Inoculation of Swiss Webster mice aged 15-18 months with human 
isolates of B. tamiae induced disease processes consistent with clinical 
manifestations of disease observed in human patients [30]. Since mice 
experience age-related changes in immune function, which include 
alterations in T-cell responsiveness to antigens, this may have affected the 
outcome of our study [256, 261]. Future studies will include younger mice to 
evaluate for age differences in response to this pathogen.  
     Two of the evaluated isolates of B. tamiae, Th239 and Th339, appear 
more pathogenic than the third, Th307 (Table 6.3). This corresponds to the 
presentation of the human patients from whom these isolates were obtained 
[30]. Patients 239 and 339 had rashes, and were febrile for 6 and 1 day(s) 
respectively, whereas Patient 307 was afebrile, and presented with 
pterygium in both eyes: all three patients had anemia [30]. In addition, the 
report of liver function abnormalities found in the human patients [30] would 
be consistent with hepatocellular disease, also seen in mice in the present 
study (Table 6.3, Figure 6.2). Immunopathological changes in the liver are 
not uncommon following human and cat infection with B. henselae or B. 
clarridgeiae [176, 262-264]. Bartonella tamiae DNA was found in the liver of 
one mouse infected with Th339 three weeks after inoculation (Table 6.2). 
Although B. tamiae DNA was detected, the question remains whether 




bacterial antigen(s) was responsible for the perivascular granulomas and 
hepatocellular necrosis seen at week 6 in our mice (Table 6.3). It remains 
unclear whether any of the lesions observed were induced, and persisted or 
progressed in the presence or absence of viable bacteria.  
     It is unknown whether the three human patients infected with B. tamiae 
had cardiac disease [30]. No clinical tests were reported to have been 
conducted to evaluate for cardiac function abnormalities [30]. In the present 
study B. tamiae Th239 and Th339 produced myocarditis in mice, with a 
diffuse inflammatory response associated with myocardial cell necrosis within 
both ventricles (Figure 6.2). Moreover, granulomatous lesions were observed 
in both atria 5 weeks post-inoculation (Table 6.3, Figure 6.2). Myocarditis in 
humans and animals has been associated with several Bartonella species 
[263, 265-268]. Advances in diagnostic techniques have implicated B. 
quintana, B. henselae, and B. elizabethae in the majority of Bartonella-
associated human myocarditis cases [251, 269, 270], while B. vinsonii 
subspp. berkhoffii seems to be the main cause of Bartonella induced 
myocarditis in dogs . Histopathological findings in experimentally infected 
cats and in naturally acquired human and dog cases of Bartonella myocarditis 
are consistent with our observations in mice .[263, 265, 271]. Shared 
characteristics of infection of heart tissue among these cases and our murine 
model include mixed inflammatory infiltrates , and myocyte necrosis  with 





     To our knowledge this is the first report of myocarditis associated with 
the inoculation of B. tamiae. Though mice had a diffuse myocarditis and no 
endocarditis was found in hearts sampled during our study (n = 4; hearts 
sampled from experimentally inoculated mice at weeks 4 and 5), it is 
intriguing to note that a high rate of culture negative infective endocarditis 
exists in Khon Kaen, Thailand [272]. This is the same area where the 
patients reside from whom B. tamiae was isolated [30]. In the human 
endocarditis cases the causative agent(s) is unknown but the possible 
involvement of bartonellae has not been stringently evaluated [272]. In Thai 
patients with infective endocarditis the mean period of time from symptoms 
to diagnosis was 5.7 weeks [272] and our present study only lasted to 6 
weeks with mouse hearts sampled at weeks 4 and 5 only. Further evaluation 
of our mouse model for B. tamiae induced disease may reveal more 
extensive cardiac involvement, especially in the context of a longer term 
study. Additional studies are also needed to determine the 
immunopathogenesis of these lesions in this murine model. 
     Lymphadenitis with and without vasculitis was seen in mice inoculated 
with B. tamiae Th239 and Th339 and sacrificed at weeks 5 and 6, and week 
6 respectively (Table 4). This is consistent with presentations of bartonella 
infections in human patients as lymphadenitis is a common symptom in 
immunocompetent humans infected with B. henselae [273]. It has also been 
observed in humans during infection with B. quintana [274] and B. alsatica 
[186], and in dogs [275] and cats infected with B. henselae [237]. Though 




in those three lymph node samples. A recently published B. henselae ‘cat 
scratch disease’ mouse model also reported persistent lymphadenopathy in 
mice without detection of bacteria in the lymph nodes [211]. Conversely, in 
this study at week 5, B. tamiae DNA was detected by PCR in the lymph node 
of a mouse inoculated with Th339 (Table 6.2), but lymphadenitis was not 
observed in those tissues under microscopic examination. It appears that the 
presence of bartonella DNA is not necessarily a predictor of pathology in the 
lymph nodes. Interestingly, of the four mice in our study inoculated with B. 
tamiae Th307, none displayed lymphadenitis which supports our conclusion 
that this isolate differs in pathogenicity compared to strains Th239 and 
Th339. 
     As little is known of the natural history of B. tamiae in Thailand it is 
difficult to assess and quantitate human risk for acquiring infection with this 
suspected human pathogen [30]. Although a specific animal reservoir for the 
bacteria has not been identified, the epidemiological profile of the three 
patients shows some shared exposures congruent with Bartonella bacterial 
infections manifesting most often as zoonoses [30]. All three patients had a 
history of exposure to rats and two had noted the appearance of rats in their 
homes in the weeks prior to the onset of their illness [30]. In recent years a 
number of rodent associated Bartonella species have been isolated from 
patients exhibiting a wide variety of clinical illnesses [61]. These cases 
include B. elizabethae: endocarditis [61], B. grahamii: neuroretinitis [61], B. 
washoensis: myocarditis [61] and meningitis [4], and B. vinsonii subspp. 




remains unclear how these infections as well as the human infections with B. 
tamiae [30], were acquired, whether by direct contact with an animal 
reservoir or exposure to a hematophagous arthropod. Recently, B. tamiae 
DNA was detected by PCR assay in chigger mites and ticks collected from a 
variety of rodents in Thailand [276]. This suggests the involvement of 
chigger mites, ticks, and/or rodents in the transmission of B. tamiae to 
humans in Thailand. 
     In summary, we explored the capacity of three B. tamiae strains to 
induce disease in aged immunocompetent mice. Our observations are 
consistent with the classification of B. tamiae as a human pathogen as 
inoculation with the bacteria produced necrotizing dermatitis, lymphadenitis, 
granulomatous nephritis and hepatitis, and myocarditis in mice. Disease 
characteristics observed in our mouse model correlate with what has been 
observed in other animal models and in human bartonelloses [263, 265, 
271]. This murine model lends itself to the study of the immunopathogenesis 
of bartonellosis caused by B. tamiae as it reproduces clinical symptomatology 
found in human patients in Thailand [30]. Future studies in mice will evaluate 
the role age may play in the manifestation of disease. Finally, though the 
natural host and transmission dynamics of B. tamiae are unknown at this 
time, several lines of evidence suggest that rodents and/or ectoparasites can 








LABORATORY MOUSE MODELS REPRODUCE HOST-BACTERIA INTERACTIONS  
     Research reported in this dissertation was aimed at developing mouse 
models for bartonella bacteria research. In doing so we explored the concept 
that taxonomic distance between host of origin and incidental host could be a 
predictor for bartonella infection outcome. Bartonella strains originating from 
diverse mammalian hosts were evaluated in a common system, the 
laboratory mouse, M. musculus. Mouse models were developed that span the 
continuum from seemingly benign infections to disease. The use of the 
commonly accepted laboratory mouse model in all our experiments in 
essence ignores the very real differences between human and mouse 
physiology. Certainly, a direct translation of effect and response of mice to 
infection would be inappropriate, but laboratory mice are accepted 
surrogates for humans in infectious disease studies, and little research in this 
area could be conducted without the use of such surrogates. In evaluating 
the taxonomic distance concept, we treated mice as equivalent to humans in 
our taxonomic distance categories, and we do recognize that this is in fact 




controlled experiments. The validity of using the mouse as a surrogate for 
humans in our experiments still needs to be shown, once more information 
about human infections with zoonotic bartonellae is collected. 
     As predicted by the taxonomic distance concept, mice inoculated with Mus 
spp. origin bartonella strains displayed a response to infection that matches 
what we know about naturally acquired infection kinetics in rodents. As we 
advanced along the continuum of infection outcomes we found that three of 
four rat bartonella strains failed to infect mice, an example of bacterial host 
specificity at the genus level. These three strains seem to circulate almost 
exclusively in Rattus spp. in nature. The fourth rat bartonella strain 
successfully infected mice, not surprising as this strain infects a much 
broader host range in nature than the other isolates. Dose dependent 
responses following exposures including months long delays in bacteremia 
onset in infected mice have important implications for how we think about 
the transmission dynamics of these bacteria in natural maintenance cycles.  
     A shrew origin B. elizabethae strain infected three different laboratory 
mouse stocks. Since this strain is closely related to rat bartonella strains we 
might predict only a 25% probability (1:3 odds) of it infecting mice, based on 
the outcome described in Chapter 3—but against these odds it did. This 
suggests the intriguing possibility that when bartonella strains in nature jump 
from their natural hosts to non-natural hosts, i.e. sympatric mammals, they 
may undergo adaptive changes that allow the bacteria to infect a broader 
host range. Host switches in nature may precede the emergence of strains 




    Though taxonomic distance between host of origin and incidental host 
appears to be a robust predictor of infection outcome, differences in 
individual host susceptibility in these dose controlled experiments were 
impossible to ignore. A review of the epidemiological features associated with 
human infections reinforced the idea that host factors may also be a powerful 
predictor for infection outcome (Chapter 1, Table 1.2). The demographic 
trend among patients with moderate to severe bartonella-associated illnesses 
showed 30% had co-morbidities and almost all were middle aged or older 
(Chapter 1, Table 1.2). In addition, a review of published literature indicated 
that no outstanding candidates for bartonella infection susceptibility existed  
among mouse strains evaluated (Chapter 1, Table 1.3). Therefore, in an 
attempt to add more sensitivity to our ability to induce bartonella-associated 
disease states we began using aged immunocompetent mice in our 
experiments. Aged mice responded as predicted to infection with a Mus spp. 
origin bartonella strain by producing high level bacteremias, whereas mice 
inoculated with B. tamiae, a presumptive human pathogen, were 
abacteremic. This indicated that aged mice would not have a universal 
bacteremic response to inoculation of any bartonella strain. Subsequently we 
showed that aged mice displayed organ pathology following inoculation with 
B. tamiae. The multi-organ pathology observed in the mice was consistent 
with symptomatology of human illness presumptively caused by this 
bacterium.  
     The four mouse models reported in this dissertation constitute scientific 




to humans, they have a short generation time, are easy to handle and 
inexpensive to maintain relative to other laboratory animals, and are 
amenable to genetic manipulations. They are unmatched in their usefulness 
and convenience in infectious disease research.  
     Much is currently unknown about bartonella bacteria: their natural history 
and ecology, their interactions with hosts and potential arthropod vectors, 
and their mechanisms for bacterial persistence and pathogenesis. Research 
interest in these areas has never been lacking, what has been lacking are  
suitable ‘tools in the toolbox.’ We present these four mouse models as new 
‘tools’ to advance understanding of bartonella bacterial interactions with 
natural and incidental hosts. The potential exists for these models to be used 
to investigate numerous aspects of bartonella ecology, vector transmission, 
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